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Abstract
Background: Sleep disturbances and deprivation are known to exist in the critically ill
patient. Over a 24-hour period, the critically ill can have 7-9 hours of sleep, but as much as 50% 
of that sleep can occur during daytime hours, signifying significant sleep fragmentation.
Furthermore, some critically ill patients have been found to have abnormal brain waves that 
obliterate normal sleep architecture. These patients are without conventional sleep markers 
exhibiting no Stage II sleep spindles, minimal rapid eye movement sleep, and slow 
background brain wave reactivity. Disrupted sleep has been associated with delirium, 
weakened immune system, impaired wound healing, nitrogen imbalance, and negative cardiac, 
pulmonary, and neurological consequences which may all lead to negative patient outcomes.
Objective: The objective of this dissertation was to explore factors and outcomes
associated with sleep disturbances in critically ill patients. The state of knowledge related to 
sleep and delirium in critically ill patients were explored. The tools and challenges of measuring 
sleep in patients while in the intensive care unit (ICU) were also explored.
Methods: Using a data base from retrospective chart review of 84 subjects, factors 
and outcomes related to the presence or absence of sleep in critically ill patients were 
explored. Literature reviews determined the state of knowledge related to sleep and delirium 
and the measurement of sleep in critically ill patients.
Results. Severity of disease was significantly associated the absence of sleep architecture in 
both the continuous electroencephalogram (cEEG) 1 to 2- and 1 to 5-day groups. Propofol was 
significantly associated with the presence or absence of sleep architecture in the day 1-2 group.
After adjusting for age and medications, serum creatinine and neurologic physiologic state during 
days 1 to 2 of cEEG are factors associated with no sleep architecture using bi-variate analysis.
Multivariate logistic regression adjusting for age and medications during Days 1-2 cEEG found 
abnormal serum creatinine to be statically significant. After adjusting for age and medications,
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encephalopathy and developmental disability were factors significantly associated with no sleep 
architecture in the Day 1-5 group. . Multivariate logistic regression adjusting for age and 
medication during days 1-5 cEEG found the physiologic states of encephalopathy and 
developmental disability to be significantly associated with the absence of sleep architecture. The 
patient outcomes of increased mechanical ventilation days, ICU length of stay and hospital 
length of stay were associated significantly with no sleep architecture during Days 1-2 cEEG. In 
the 1-5 Days cEEG group, hospital length of stay was significantly associated with no sleep 
architecture. Post-hospitalization transfer location was associated with no sleep architecture for 
both cEEG groups. Discharge to home was associated with the presence of sleep architecture.
Conclusions: Certain patient characteristics are associated with the presence or absence
of sleep architecture. The presence or absence of sleep architecture may impact patient 
outcomes. The exploratory study indicates that future prospective research with larger sample 
sizes and sleep architecture specifics is needed to advance the state of knowledge. While 
delirium theoretically may be related to sleep disturbances, more research is needed to determine 
if a correlation exists. Measuring sleep architecture in ICU patients can be challenging. Critical 
illness can impact the reliability and accuracy of sleep measurement tools including the gold 
standard polysomnography. Researchers need to be clear in their research goals and know the 
challenges related to the various sleep measurement tools.
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Chapter 1:
Introduction
One of the chief complaints of former intensive care unit (ICU) patients is sleep 
deprivation. Patients have indicated that the ICU environment disrupts circadian rhythms and 
disturbs sleep resulting sleep deprivation (Kiekkas et al., 2010; Lusk & Lash, 2005; DeKeyser, 
2003, Fontana & Pittigloi, 2010). Qualitative research has shown that 54% of critically ill 
patients reported difficulty falling asleep in the ICU setting with close to half identifying noise as 
the causal agent (Hofhuis et al., 2010). However, many patients are unable to remember their 
ICU sleep experience related to their critical illness and/or medications making the sleep state in 
the critically ill difficult to determine.
Normal Sleep Architecture
Sleep is a complex process characterized by physiologic, behavioral and brain wave 
changes necessary for the restoration of cognitive, mood and physiologic functions (Kamdar, 
Needham, & Collop, 2012; Hardin, 2009). Normal sleep architecture consists of four to six 90 to 
100 minute periods during which non-rapid eye movement sleep (NREM) and REM alternate in 
a cyclical fashion. The period of NREM is comprised of Stages 1–3, each stage having unique 
brain wave activity. REM sleep is distinguishable from NREM sleep by changes in physiological 
states, including its characteristic rapid eye movements and occurs approximately 90 minutes 
after sleep onset. All stages are necessary for a restorative sleep process.
Polysomnography
Polysomnography (PSG), commonly called a sleep study, measures brain waves, oxygen 
levels, electrocardiogram, and various muscle movements. PSG, considered the gold standard of 
sleep measurement, is able to determine the quality and quantity of sleep. However, utilizing 
PSG to determine sleep architecture in the critically ill patient is cumbersome, expensive, and 
potentially inaccurate. Illness, injury and medications may interfere with the ability to accurately
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analyze PSG brain wave data. Studies employing PSG in critically ill patients often use 
extensive inclusion and exclusion criteria to insure complete and accurate sleep data, thereby 
limiting generalizability. Electroencephalogram (EEG) tracks and records brain wave activity. 
EEG data analysis can determine general patient sleep information but would have difficulty 
differentiating between wakefulness, Stage 1 and REM sleep (Estrada et al., 2006). EEG can be 
used be as a preliminary screening to determine if a patient has sleep architecture or normal 
brain waves that could sustain sleep.
Sleep in the Critically Ill Adult
Over a 24-hour period, critically ill patients can have an adequate 7-9 hours of sleep, but 
as much as 50% of that sleep can occur during daytime hours, signifying significant sleep 
fragmentation. Sleep fragmentation causes short bursts of sleep, resulting in a predominant N1 
sleep stage with scarce time in restorative Stage 3 and REM sleep stages. For example, Friese et 
al. (2008) found that mechanically ventilated surgical patients average 8.25 hours of sleep, but 
96% of the total sleep time was spent in stages 1 and 2. Sleep was disrupted by multitude of 
awakenings and arousals. Furthermore, some critically ill patients have been found to have 
abnormal brain waves that obliterates normal sleep architecture. These patients are without 
conventional sleep markers exhibiting no Stage 2 sleep spindles, minimal REM and slow 
background reactivity (Cooper et al., 2001; Drouot et al., 2011).
Sleep Disruption Outcomes
Even in healthy volunteers, sleep deprivation can lead to memory deficits, emotional 
imbalance, and slow reaction time with impaired attention, critical thinking, and recall (Maldonado, 
2008). Disrupted sleep has been associated with a weakened immune system, impaired wound 
healing, nitrogen imbalance, and negative cardiac, pulmonary, and neurological consequences 
(Hardin, 2009; Bihari, 2012). By weakening upper airway musculature, sleep deprivation can 
interfere with efforts to wean patients from mechanical ventilation leading to
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longer ICU length of stays (Celik et al., 2005). Additionally, sleep deprivation is theorized as a 
major contributor to delirium. Delirium is a state of confusion marked by a change in cognition 
associated with medical illness. Delirium in the critically ill has been associated with longer 
ICU and hospital lengths of stay, increased complications, longer mechanical ventilation time 
and higher mortality (Zhang et al., 2013). If sleep disruption and deprivation negatively impacts 
critically ill patients, having no discernable sleep architecture would also theoretically be 
associated with poor patient outcomes.
Summary
Disturbed sleep architecture has been associated with negative patient outcomes. 
Therefore, patients exhibiting no sleep architecture as determined by EEG monitoring would 
also be at risk for a higher rate of negative outcomes such as increased ICU and hospital stays, 
longer mechanical ventilation days, post-hospitalization discharge locations that are different 
from baseline (e.g., coming to the hospital from home but discharged to a nursing home), and 
higher mortality.
Purpose
The primary purpose of this dissertation is to describe the association between patient 
outcomes and no sleep architecture per EEG analysis in critically ill patients per a 
retrospective chart review from April 2015 to January 2016. Manuscripts presented reviews 
exploring the association between sleep and delirium in critically ill adults and the use of PSG 
in critically ill adult patients are also included.
Dissertation Aims
Aim 1. Determine the state of the knowledge related to an association between sleep 
and delirium in adult critically ill patients.
Aim 2. Determine the state of the knowledge in how to implement polysomnography in
the critically ill and obtain comprehensive, accurate sleep data.
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Aim 3. Explore factors associated with the finding of no sleep architecture in 
critically patients with EEG ordered as part of their plan of care.
Aim 4. Examine patient outcomes (mechanical ventilation days, hospital length of 
stay [LOS], ICU LOS, post-hospitalization discharge locations, and mortality) associated with 
no sleep architecture per EEG monitoring in critically ill patients.
Significance
The work presented in this dissertation will add to the limited body of research that 
explores the association between no sleep architecture and patient outcomes in critically ill 
patients. Next, a literature review will examine the association between sleep and delirium while 
providing recommendations for future research. While sleep disturbances are theorized to 
contribute to the delirium, limited research has been conducted measuring both sleep and 
delirium in critically ill patients. Additionally, the use of polysomnography in critically ill adult 
patients will be examined adding to the body of knowledge in regard to implementing this 
method of sleep data collection in the ICU environment.
Organization of Dissertation
This dissertation is organized into five chapters. Chapter 1 provides an introduction, 
purpose, aims, and organization of the dissertation. Chapter 2 consists of a manuscript that explores 
the state of the knowledge of an association between sleep and delirium in critically ill adult patients. 
This literature review will examine the strength of the association between sleep and delirium along 
with factors such as delirium measurement instruments, sleep measurement methods, age, diagnosis, 
ventilation, and sedation that may impact any findings. Chapter 3 examines sleep measurement in the 
critically ill patient with a focus on PSG. Barriers to implementing PSG along with inclusion and 
exclusion criteria used in studies to insure accurate, usable sleep data are explored. Chapter 4 
reviews the finding of no sleep architecture in critically
ill patients with EEG ordered as part of their plan of care. A preliminary EEG screening for sleep 
4
architecture for a sleep intervention study surprisingly found the majority of patients had no 
sleep architecture. An overview of the number of patients screened and the EEG findings is 
given. Chapter 5 discusses the research findings exploring an association between no sleep 
architecture and patient outcomes along with possible future research recommendations.
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Synopsis
Delirium, an acute brain dysfunction, is a common complication of the intensive care 
unit (ICU) having both short and long term negative consequences. Poor sleep quality as 
evidenced by decreased total sleep time, sleep fragmentation, and disturbed sleep architecture has 
been a prevalent finding in critically ill patients. Theoretically, delirium and sleep disturbances 
are believed to be related, although the exact relationship is unclear. Multiple factors seem to 
contribute to ICU sleep disturbances and/or delirium making the measurement and analysis of 
their relationship challenging. Understanding the strength of the correlation between sleep and 
delirium can guide nursing practice and the development of interventions to improve sleep and 
decrease ICU delirium. This review of the literature was conducted to determine the state of the 
knowledge on the association between sleep and delirium in critically ill patients. A search of 
Medline and CINAHL using the key words of “delirium”, “sleep/sleep disorders” and “critical 
care/intensive care units” yielded nine articles and one dissertation after applying inclusion and 
exclusion criteria. Research directly related to both sleep and delirium in the ICU is minimal, but 
synthesizing the studies may help guide nursing interventions and direct future research to be 
conducted in this area important to critically ill patients.
Key Words: Delirium, Sleep, Sleep disturbances, Critical Illness
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Sleep and Delirium in the Critically Ill Patient: A Comprehensive Literature Review
Delirium is an acute brain dysfunction that is a common complication experienced by 
critically ill patients. Delirium is characterized by the acute onset of cerebral dysfunction, change 
or fluctuation in baseline cognition, inattention, and either disorganized thinking or an altered 
level of consciousness.1-6 Patients with delirium may be agitated and distracted with delusions 
(hyperactive delirium), or lethargic, inattentive, and withdrawn (hypoactive delirium). Mixed 
delirium is identified by a fluctuation between hyperactive and hypoactive delirium types.1, 7 It 
has been documented that ICU patients have a high risk for developing delirium with incidences 
ranging from 11% to 80% depending on setting, population, and study design.4,8,9 ICU delirium 
has been linked to poor short and long-term outcomes.6, 10 Delirious patients are more likely to 
experience acute respiratory distress syndrome (ARDS), nosocomial pneumonia, 
cardiopulmonary edema, self-extubation, re-intubation, cardiac arrhythmias, and to be 
discharged to a skilled nursing facility.11-13 Additionally, mechanical ventilation days and length 
of stay in the ICU and hospital may increase in patients diagnosed with delirium.14, 15
Sleep is a complex process characterized by physiologic, behavioral and brain wave 
changes necessary for restoration of cognitive, mood and physiologic functions.16,17 Normal 
sleep architecture consists of two distinct stages: nonrapid eye movement (NREM) and rapid eye 
movement (REM). Human sleep patterns normally consist of four to six 90-100 minute periods 
where NREM and REM alternate in a cyclical fashion.17,18 NREM is further divided into three 
stages: N1, N2, and N3 or slow wave sleep (SWS) each with their own characteristics and 
properties (See Table 2.1). Sleep fragmentation, short bursts of sleep resulting in predominant 
N1 sleep stage with minimal time in the restorative sleep stages SWS or REM, is a common ICU 
finding. Even when total sleep time (TST) for a 24-hour period is adequate (7-9 hours), 50% of 
TST may occur during daylight hours indicating significant sleep fragmentation.17, 21,22
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Table 2.1
Normal Sleep Stages
Sleep Stage % Total EEG Characteristics Brain Activity
Sleep Time
N1 or light sleep 2%-5% Low voltage theta waves (4-8 Entry into sleep from
(NREM) Hz) wakefulness
N2 (NREM) 45%-55% Slower, high amplitude waves, Deepening sleep;
K-complexes & sleep spindles transition to N3
N3 or Slow Wave 15%-20% High amplitude delta waves High arousal
Sleep (SWS) or (0.5-2 Hz) threshold; restorative;
Deep Sleep (NREM) memory consolidation
REM 20-25% Low voltage, high amplitude, Dreaming; perceptual
mixed frequency beta & saw- learning
tooth theta waves
More than 50% of ICU patients have been found to suffer from sleep disruption as 
evidenced by abnormal sleep duration, patterns, and architecture related to critical illness or the 
ICU environment.20 Former ICU patients identified lack of sleep or rest as the most frequent, 
burdensome, and annoying ICU experience during their ICU stay.19
Sleep deprivation can lead to memory deficits, emotional imbalance, and slow reaction 
time with impaired attention, critical thinking, and recall.23 Disrupted sleep has been associated 
with a weakened immune system, impaired wound healing, nitrogen imbalance, and negative 
cardiac, pulmonary, and neurological consequences.17, 24 Sleep deprivation may consequently 
lead to increased ICU length of stay and increased mortality.1,5,6
ICU delirium has been shown to be a multifactorial process with sleep disruption 
hypothesized to be a factor in its development. While exact delirium etiology is unknown, sleep 
deprivation and delirium affect the same regions of the central nervous system: the prefrontal cortex 
and posterior parietal cortex.5,25 Delirium has been described as a neurobehavioral syndrome caused 
by dysregulation of neuronal activity.23 An imbalance of neurotransmitters may
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explain both delirium and sleep disturbances. A deficiency in the cholinergic system and excess 
dopaminergic stimulation may produce the attention deficit, motor activity, mood, and memory 
changes found in delirium. The cholinergic system is also involved in creating REM sleep. Low 
levels of cholinergic neurohormones may decrease REM sleep and contribute to delirium.5,25
Melatonin hormone levels influenced by dopamine and light exposure can result in disruptions 
to the 24 hour circadian biological clock.2,25 Dementia, old age, and psychotropic medication 
are known risk factors for delirium that are associated with impaired melatonin secretion or 
function.26-28
In view of the high prevalence of ICU delirium and the adverse outcomes for patients 
and society, determining and understanding the relationship between sleep and delirium is 
necessary to guide healthcare interventions and direct future research. The present review of the 
literature was conducted to determine the state of the knowledge on the association between 
sleep and delirium in adult critically ill patients.
Method
The keywords used in the search strategy completed in October 2018 were “delirium”, 
“sleep/sleep disorders”, “critical care/intensive care units”. The search limits were 1) human and
2) English language. Articles identified using the keywords in Medline or CINAHL were 
reviewed using the following inclusion and exclusion criteria: Research articles were required to 
measure both sleep and delirium in an intensive care unit; review articles, case studies and 
articles using secondary data analysis of an included article’s data were eliminated. The reference 
list of reviews, studies, and editorials were hand searched for additional studies. Titles and 
abstracts were screened in order to evaluate studies for inclusion according to eligibility criteria.
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Results
One hundred thirty-three articles were identified through the database search. One 
article was located per the reference list of a review article. A total of nine articles and one 
dissertation met the inclusion criteria. Articles were excluded for the following reasons: not 
relevant to the research question (n=50) and duplicates (n=74). Table 2.2 summarizes the studies 
and their relevant components.
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Table 2.2
Summary of Study Findings
Reference, Study Aim Subject n/ Study Design Sleep Delirium Study Findings
Year Setting and Measurement Measurement
Intervention
van de Pol Assess whether protocol n=211, pre- Interrupted time RCSQ-end of night ICDSC Delirium significantly
et al.34 reducing nocturnal test series; pre-test shift Three times reduced post noise
2017 sound levels decreases n=210, post- post-test Extra question daily reduction protocol. Quality
incidence of ICU test added related to of sleep unaffected
delirium & improves Medical noise
sleep Surgical
ICU prospective
Boesen et Netherlands observational CAM-ICU
al.31 Assess sleep by PSG in PSG-24 hours Once per 1 patient no delirium &
2016 relation to n=14 Scored American shift sleep; 3 patients no
Delirium in MV non- Mixed ICU Pilot Study Associ- delirium & atypical
sedated ICU Prospective, ation of Sleep PSG/no sleep. 
Vacas et patients observational Medication CAM-ICU delirium & atypical PSG; 4
al.38 n=23 Twice daily patients CAM
2016 Investigate feasibility & ICU Pilot Study Portable EEG assessable
utility of monitoring USA Prospective, monitor
sleep in ICU setting observational Analyzed by board ICDSC Occurrence of delirium not
Whitcomb using portable EEG n=7 certified technician Once a day significantly different
et al.30 monitor Medical, between patients with and
2014 pulmonary Wireless sleep without sleep disruption
Determine relationship ICU monitor
between sedation, USA Prospective 9pm-6am
disruptions, & sleep cohort 1-6 nights 48% awake (range 8
using a sleep monitor to pre-test post- If RASS ≥- 30% light sleep (Range 2
capture actual sleep test design 4, then 50%)
Reference, Study Aim Subject n/ Study Design Sleep Delirium Study Findings
Year Setting and Measurement Measurement
Intervention
Patel et al.32 activity compared with n=167, pre- CAM-ICU 18.5% REM (Range 2
2014 patient characteristics test Multicomponent 0800,1400, 60%)
and real-time activity in n=171, post- sleep promotion RCSQ-each and 1800 3.4% deep sleep (Range 0
the ICU test bundle morning of ICU plus 0200 if 9%)
Medical stay. 1 appropriate 1 subject had ICDSC 4,3
Investigate the Surgical questionnaire per with 88% awake, 4 % deep
implementation of a ICU patient randomly sleep and 2% REM sleep
bundle of non- UK Prospective selected to be
pharmacological cohort pre-test included in data Post intervention group
interventions, consisting post-test design analysis. Sleep in had significantly more
Kamdar et of environmental noise Intensive Care CAM-ICU sleep efficiency, sleep
al.33 and light reduction Question-naire. twice daily quality night time sleep
2013 designed to reduce Nurse assess if and 3 hour sleep windows
disturbing pts during n=122, pre- Randomized patient asleep or with a reduction in daytime
night test clinical trial awake each hour sleepiness. Subjects
n=178, post- reported less noise, light,
test RCSQ daily unless NEECHAM & nursing interventions
Van General RASS≤-4, RCSQ scale 0800, Post intervention group
Rompaey et ICU not completed 1400, 2200 had a reduction in the
al.36 To determine if a quality USA Prospective, if.CAM-ICU + or incidence of delirium: 33%
2012 improvement observational nurse completed before vs, 14% after,
intervention improves design RCSQ if patient p<.001; OR 0.33 (95% CI
sleep and delirium/ n=69, unable When 0.19
Cognition earplug RASS≤2, Mean length of time
Trompeo et intervention Patient response to CAM-ICU delirious 3.4 days pre
al.29 n=67 5 sleep questions twice daily (SD 1.4) vs 1.2 days post
2011 Explore the use of control test (SD 0.9)
earplugs during the night
Reference, Study Aim Subject n/ Study Design Sleep Delirium Study Findings
Year Setting and Measurement Measurement
Intervention
reduces delirium & General Prospective, No significant difference
improves the quality of ICU observational in sleep measures between
sleep in the ICU Belgium design PSG manually groups. Pre
analyzed per CAM-ICU overall better sleep quality.
n=29 Rechtschaffen and every Fewer patient days of
Campo et To assess the General Kales criteria 12 hours delirium/coma free status
al.37 characteristics of sleep ICU 1 night-10:00 pm- in pre
2010 disruption in a cohort of Italy 8:00 am post
surgical critically ill Prospective
patients examining the comparative
hypothesis that severe design Sleeping with earplugs
impairments of rapid eye lowered incidence of
movement sleep are PSG manually CAM-ICU confusion & confusion
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Sleep Time
Study Characteristics
While all of the ten studies that were selected included sleep and delirium as variables, 
the purpose of the studies widely varied. Three prospective observational studies focused on the 
relationship between sleep disruption, delirium, and sedation.29,30,31 Two studies examined 
outcomes related to the implementation of multicomponent sleep promotion protocols using pre-
and post-test designs with sleep and delirium as outcome measures.32.33 Noise reduction is often 
included in sleep promotion protocols. One study focused on the effect of noise reduction on the 
incidence of delirium and the quality of sleep.34 Another study explored sedation reduction and 
ventilator weaning trials by comparing two groups that were sequentially assigned into either a 
sedation reduction wake up and spontaneous breathing trial or usual care.35 Primary outcome 
variables were the occurrence of delirium, the number of days of delirium, and patient perception 
of sleep. A randomized clinical trial studied the use of earplugs related to sleep perception, 
confusion and delirium.36 Another study used sleep and delirium as outcome measures related to 
late noninvasive ventilation failure (NIV) where NIV failure was defined as intubation, 
continued significant NIV for six days, or death.37 A final study directly explored the 
relationship between ICU delirium and sleep disruption.38
Sample Characteristics
There was a marked variation in study settings, patient age, and diagnosis. The studies were 
conducted in eight different countries with the ICU settings varying from trauma35, medical33,37, 
medical/surgical32,, medical/pulmonary30, cardiosurgical36 to general.29,31,34,38 With the variety of 
ICU settings, the patient characteristics were also diverse. Trauma ICU patients were younger 
ranging in age from 23-58 years.35 Campo and colleagues37 had an average participant age of 82 
years (range 72-85). Van Rompaey and colleagues36 subjects ranged in age from 18 to 84 averaging 
59 years. The mean age of the remaining studies was 60-68 years (range
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18-81).29-32, 34,37,38 While some studies shared the exclusion criteria of certain health variables, 
including neurological trauma or diagnosis of psychiatric diseases,29,31,32,34,35,38 as well as alcohol 
or drug dependence,29,32,35 the types of included diagnoses differed. One study, due to setting and 
inclusion requirements, had a patient population with a more homogenous diagnosis type- chronic or 
acute respiratory failure.37 Outside of the trauma ICU, studies without a specific diagnosis for 
inclusion criteria had a wide range of primary problems among their subjects.32,33 One study did not 
identify the primary diagnoses related to their subjects.36 No significant gender differences were 
evident except in the pilot study where six out of seven subjects were male.30 In four
studies, all subjects were either invasively or noninvasively mechanically 
ventilated. Two
studies did not give information related to ventilation.36,38 In the remaining studies, some, but 
not all subjects, were intubated.31,34,37
Sedation medications and opioids have been found to be correlated to both delirium and 
sleep disturbances. For this reason, some studies had criteria of no sedation at all or over a period 
of time (24-28 hours) before study enrollment.31,32,36,37 Three studies did not include the use of 
these medications in their analysis.30,33,38 Trompeo and colleagues29 found that 
benzodiazepines and delirium were independent factors associated with severe REM sleep 
reduction. Van de Pol, van Iterson, and Maaskant34 discovered a decrease in delirium and 
benzodiazepines use with the implication of a noise reduction protocol, but the quality of sleep 
was unaffected. Figueroa-Ramos,32 in her sedation wake trial study, found that the control group 
with continuous sedation infusions had an 80% delirium rate. The patients using 
benzodiazepines and propofol had more hypoactive delirium. The sedation wake-up intervention 
group had only a 30% delirium rate with a preponderance of mixed delirium.
Studies have shown a potential relationship between disease severity and the development of 
either delirium11 or sleep disturbances.41,64 Van Rompaey and collegues’36 results
29,30-33,,37
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showed a 9% increased risk of delirium as Sequential Organ Failure Assessment (SOFA) 
scores increased. Trompeo and colleagues29 found significantly higher severity of disease 
scores upon admission in the severely REM deprived cohort with a corresponding increase in 
delirium incidence rate. However multiple regression analysis revealed that severity of disease 
was not independently significant from other variables.
Sleep and Delirium
Among the ten studies, findings related to the relationship between sleep and delirium 
were mixed. Trompeo and colleagues29 measured sleep using polysomnography (PSG) to 
determine that a less than 6% of total sleep time (TST) consisting of REM sleep would equal a 
severe REM reduction. Patients with a severe REM reduction had a higher incidence of delirium. 
In a pilot study with seven patients measuring sleep with a wireless sleep monitor, the patient 
who on average was the most awake during the night (88%) with only a mean 2% REM sleep 
was determined delirious,30 whereas a patient with decreased night TST, being awake 65.8% of 
the night, did not develop delirium. A patient with only a mean 0.5% REM sleep did not develop 
delirium per the patient’s total average delirium score. Boesem and colleagues31 found that out of 
14 subjects, only one had identifiable sleep architecture. This subject tested negative for delirium. 
The other 13 subjects had atypical brain waves resulting in the inability to assess for sleep. These 
subjects tested positive, negative, or were non-assessable for delirium. One study explored how 
the use of earplugs during the night impacted sleep and delirium without directly analyzing the 
relationship between sleep and delirium.36
Five studies measured sleep using a patient report questionnaire to determine sleep 
satisfaction scores. Patel and colleagues31 found that the cohort with the best sleep efficiency, 
sleep quality, increased night sleep time, and greater number of 3 hour periods of continuous 
sleep along with a reduction in daytime sleepiness had a significant reduction in the incidence of
19
delirium between groups (33% vs. 14% p<.001). In the better sleep group, patients recovered 
from delirium quicker with a mean length of time diagnosed with delirium lasting 1.2 days (SD 
0.9) vs. 3.4 days (SD 1.4). Kamdar and colleagues34 found a difference in delirium between 
cohorts, yet there was not a corresponding difference in sleep scores. Similarly, Figueroa-
Ramos32 found a significant difference in hypoactive delirium between groups (60% vs. 5%) 
with no corresponding difference in the patient’s perception of sleep. In this study, the sedation 
reduction/breathing trial and usual care groups both self-reported sleep fragmentation, rating 
their sleep quality as “bad”. However, a considerable amount of sleep data were missing due to 
over half of the subjects being unable to complete the sleep questionnaire. Van Rompaey and 
colleagues33 used five questions to determine patients’ sleep perception with only four out of 136 
subjects unable to reply to the questions due to ongoing delirium. In this study, the intervention 
group using earplugs significantly rated their sleep higher in the first 24 hours than the control 
group without earplugs. Past the first 24 hours, sleep was not significantly better with earplugs 
and the amount of poor sleep increased for all patients. Van de Pol, van Iterson and Maaskant34
had a 65.56% completion of the RCSQ from enrolled subjects. All subjects were assessed for 
delirium. The RCSQ was not used for delirious and unconscious patients, making the relationship 
between sleep quality and delirium difficult to ascertain.
Discussion
While sleep disturbances and delirium in critically ill patients have been linked 
theoretically, supporting evidence is minimal. Multiple factors may influence the development of 
sleep disruptions and delirium. By exploring potential common factors, the potential relationship 
between sleep disruptions and delirium may become more evident.
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Sleep Measurement
Polysomnography (PSG) is considered the gold standard for measuring the quantity and quality of sleep. PSG is electroencephalography (EEG) monitoring with the additional measures of electrocardiogram, respiratory effort, pulse oximetry and various muscle movement. 
implemented in patient care due to expense and technical difficulties in the ICU setting. Most studies using PSG have small patient populations and the duration of monitoring was often only for one night or 24 hours.33 As Trompeo and colleagues29 acknowledged, the limited patient PSG data makes However, PSG is rarely 
characteristics difficult, such as the difference between a REM sleep reduction and a severe REM sleep reduction. While PSG may be considered the most reliable measure of sleep, two of the studies implementing PSG used the manual Rechtschaffen and Kales criteria75 to analyze the data. These categorizing ICU sleep 
accurate and reliable in mechanically ventilated ICU patients compared to a computer-based method.39 Part of the difficulty in analyzing PSG in the critically ill patients may be due to abnormal brain wave patterns, making the detection of sleep and wakefulness challenging.37,42 Also in two PSG criteria has been found to be less 
studies, investigators only obtained readings for one night lasting 8 or 17 hours. Research has shown that up to 50% of ICU patients’ sleep can occur during the daytime hours, thus investigators could potentially miss a significant amount of TST by measuring sleep only during the night making it difficult to make valid 
correlations of sleep characteristics and delirium.
Three studies used the Richards-Campbell Sleep Questionnaire (RCSQ) to measure perceived 
sleep quality and noise levels. The RCSQ is a patient self-reported sleep instrument that measures: 1) 
sleep depth, 2) latency (time to fall asleep), 3) number of awakenings, 4) sleep efficiency (percent 
time awake), 5) sleep quality, and 6) nighttime noise. The RCSQ has been validated with PSG in alert 
and oriented critically ill patients which differs from patients suffering
21,42-44
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from delirium.45 The Patient’s Sleep Perception Questionnaire was developed without 
psychometrics by Figueroa-Ramos to simplify gathering sleep data from intubated, critically ill 
patients, yet a large amount of sleep data is missing in this study related to patients being unable 
to complete the questionnaire.35 Van Rompaey and colleagues36 measured sleep using five 
questions instead of using validated patient sleep perception instruments stating that validated 
scales were burdensome to patients in that they were too long and required the patient’s 
sustained attention.
Common memory problems in the ICU related to critical illness, sedation, delirium or 
dementia can negatively impact the validity and reliability of patient reported instruments. This is 
particularly relevant when the outcome variable is delirium. Using a patient reported sleep 
assessment tool may result in the inability to obtain sleep data due to critical illness or generating 
unreliable data with the delirious subjects. To overcome this dilemma, nurses have completed the 
RCSQ for subjects unable to do so for themselves due to delirium or communication hindrances 
after having tested the validity of nurse and patient reports using the RCSQ. However, nurses 
have been found to over report total sleep time when compared to PSG.39 In the Van Rompaey 
and colleagues36 study, the inclusion and exclusion study criteria included a Glasgow Coma 
Scale >10 and no sedation which insured that a vast majority of subjects in a study were able to 
answer patient sleep perception questions while limiting generalizability of results.
Two studies used unique methods to measure sleep. Whitcomb and colleagues30 used a 
wireless sleep monitor that was developed for personal home use that had not been tested in clinical 
settings as a result, data validity was lacking. The feasibility of utilizing a portable 
electroencephalography (EEG) monitor to measure sleep in critically ill patients was explored by 
Vascas and colleagues.38 In a sleep laboratory, the portable EEG monitor was able to recognize sleep 
stages, transitions and arousals in enrolled subjects. However, in comparing PSG and the
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portable EEG monitor, the investigators found a difference in the accuracy of the portable 
EEG monitor to measure different sleep stages.
Delirium Measurement
Currently, there is no accepted bio-physiologic marker for delirium, although changes 
in brain waves per EEG monitoring has been explored.45 Acute changes in baseline 
consciousness and cognition are hallmark features of delirium. Assessment of these changes 
usually depend on secondary sources (e.g., family, friends, health care staff and medical history) 
as the potentially delirious ICU patients are unable to recognize changes or provide accurate 
information. The Confusion Assessment Method-ICU (CAM-ICU) was developed to quickly 
and easily identify the presence or absence of delirium in mechanically ventilated and non-
ventilated patients in the ICU with high reliability and validity.47 As the presence of delirium is 
known to fluctuate, the five studies utilizing the CAM-ICU had 2-4 data points in a 24-hour 
period. The Richmond Agitation Sedation Score (RASS) along with CAM-ICU may be used to 
determine whether delirious subjects are in hypoactive (CAM-ICU positive, RASS 0 to -3) or 
hyperactive (CAM-ICU positive, RASS +1 to +4) delirium.35 Hypoactive delirium has been 
linked to sleep deprivation and poorer outcomes compared to hyperactive delirium.35
In contrast, the Intensive Care Delirium Screening Checklist (ICDSC) is an eight-point 
system to determine risk for and presence of ICU delirium with a score of 4 or greater indicating the 
presence of delirium. Compared to the CAM-ICU, the ICDSC has moderate sensitivity and good 
specificity.48 While the CAM-ICU is dichotomous, the ICDSC can be used as a continuous variable 
showing decreasing or increasing delirium symptoms.48 Whitcomb and colleagues30 used the ICDSC 
only once a day possibly missing delirium fluctuations. They did report a subject who was awake 
nearly 68% of a night, but did not have delirium since the subject’s overall mean ICDSC score was 
3.2. Using ICDSC, a subsyndromal delirium can be detected (ICDSC 1-3)
23
which is a state between no delirium (ICDSC=0) and clinical delirium (ICDSC=4).49
Subsyndromal delirium has been found to potentially increase hospital length of stays and the 
need for convalescence care upon hospital discharge compared to patients with no delirium.49
One study utilized the NEECHAM Confusion Scale which was designed to identify 
signs of developing acute confusion and measure its severity.50 The NEECHAM scale has been 
found to have strong reliability and validity in elderly non-critical care patients.50,51,52 Minimal 
psychometric testing of this scale has been completed in the ICU setting particularly in 
mechanically ventilated patients52.53 resulting in the pain, agitation, and delirium guidelines not 
recommending the use of NEECHAM in the ICU setting.1 The 30 point NEECHAM scale has 
four categories for results: 30-27 “normal”, 26-25 “at risk”, 24-20 “early to mild confusion” and 
19-0 “delirium or acute confusion”. The meaning for patients and the predictive values of the “at 
risk” and “early to mild confusion” categories has not been explored. If these categories were 
found to have value in predicating delirium, this scale could be useful in testing interventions to 
prevent and treat delirium.
Age
Elderly patients have been found to be more prone to both sleep disturbances and 
delirium. In elderly patients, delirium is a prevalent complication related to hospitalization.13,54
Post-surgical elderly patients with poor sleep patterns or sleep satisfaction were more likely to be 
diagnosed with delirium.55-57 Even in healthy elders, there can be a measurable decrease in sleep 
with less SWS, REM sleep, and TST, and more awakenings, length of awakenings and daytime 
sleep hours.55-58 At baseline, elderly patients are more likely to have poor perceived sleep or 
sleep satisfaction making a correlation between sleep disturbances and delirium difficult in this 
population. In the majority of the studies, age was not included in the final analysis. This was 
mainly because age was not significantly different between groups which does not capture the
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relationship between sleep, delirium, and age. Van Rompaey and colleagues36 found that the 
risk for mild confusion or delirium increased by 3% per year of life. Additionally, Figueroa-
Ramos35 did find that when group assignment, benzodiazepine, and propofol were controlled 
for every additional year in age, the odds of being delirious increased by 7%. However, the 
overall mean age was 32.5 years with the oldest subject being 58 years old; thus, no elderly 
patients were included in the study. Kamdar and colleagues33 did include age in their analysis, 
but found no relationship between age, sleep disturbances and delirium. In the aged population, 
baseline cognitive dysfunction has been found to be a risk factor in the development of delirium 
and this rather than age itself may contribute to delirium.
Diagnosis
Various diagnoses have been linked to the development of delirium and sleep 
disturbances in the critically ill. The small pilot study did not include information related to 
diagnosis,30 while in the other studies the types of diagnoses varied widely. Four studies 
eliminated patients with a history and/or current abuse of alcohol or drugs.29,32 Undergoing 
substance withdrawal can lead to a hyperactive delirium, potentially confounding any analysis 
that developing delirium is related to sleep disturbances. Diagnoses of dementia29,32,33,38 and 
various psychiatric29,32 or neurological29,31,34-36,38 disorders were also excluded. While acute 
neurological diagnosis (e.g., stroke) may impact wakefulness and higher cognitive function on 
the CAM-ICU, these patients can still be assessed for delirium and sleep. Using the ICDSC to 
assess for delirium has been found to be feasible for this patient population.59 While not every 
item on the ICDSC is always valuable in the neuro-critically ill, the increasing or decreasing 
trend even at the low end of the scale gives valuable information related to the presence or risk of 
delirium.59 Additionally, PSG analyses can be impacted by certain neurological 
diagnoses,41,60,61 making the study of sleep and delirium in this patient population challenging.
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Sedation
Benzodiazepines and opioids are frequently used for sedation in ICU patients; both have 
been found to disrupt sleep cycles by decreasing slow wave and REM sleep phases.62
Additionally, sedation medications can potentially cause increased REM intensity over shorter 
time durations which can provoke nightmares and directly affect memory,62,63 contributing to the 
disorientation and decreased attention span found in delirious patients. Benzodiazepine was 
found to be an independent factor, along with delirium, associated with severe REM sleep 
reduction.29 Discerning whether patient symptoms can be contributed to sedation, opioids or 
delirium is difficult, which explains why some studies require these types of medications to not 
be administered to subjects 24-48 hours before subject enrollment.32,36,373 However, withdrawal 
reactions can also lead to profound sleep disruption and delirium in critically ill patients and is 
mostly due to sedative agents for mechanical ventilation.62 Discontinuation of sedation and 
sedation reduction protocols need to take into consideration that any new delirium noted may be 
related to withdrawal, along with the consideration that the patient is now awake enough to be 
assessed for delirium.35 While propofol was not found to be a significant factor related to sleep or 
delirium in these results, a crossover study using PSG found that propofol was related to less 
REM sleep and further worsened already poor sleep quality.64 Even dexmedetomidine has been 
shown to influence memory formation and learning and is hypothesized to interrupt normal sleep 
cycles via alterations in REM and NREM sleep.62,63
Ventilation
Among mechanically ventilated patients, delirium has been found to be a predictor for 
longer hospital stays, more days on the ventilator, and increased mortality, but the associations 
between mechanical ventilation, delirium, and sleep are not obvious.14,15,65 Trompeo and 
colleagues29 started one night of PSG recording after ventilator weaning was initiated at pressure
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support ≤10 cm H2O, positive end-expiratory pressure (PEEP) ≤ 5. All subjects were considered 
to have a reduction in REM sleep. Due to delirium being measured in the days following the one 
time PSG recording, a correlation between sleep, delirium and ventilation mode was unable to 
be discerned. During sleep, particularly in NREM stages, voluntary control of breathing is lost 
and reactivity to hypoxia and hypercapnia tend to decrease. This results in more arousals and 
sleep fragmentation which may explain the overall REM reduction found in these subjects on 
pressure support ventilation.16 Pressure support has been shown to result in more sleep 
fragmentation compared to assist control (AC) or pressure control (PS) ventilation modes.66,67
Yet in a different study, sleep was equally poor using AC or pressure support ventilator 
settings,68 indicating the complexity of determining factors related to sleep disturbances. 
Noninvasive ventilation (NIV) failure after a minimum of 48 hours was correlated with impaired 
sleep and delirium when controlling for other variables.36 NIV has been found to improve sleep 
in hypercapnic ICU patients compared to unassisted breathing.36
Other Factors
More than 60 different variables have been studied in relation to the development of 
delirium both in and out of the ICU making it difficult to determine the variables to include in 
delirium and sleep research.4 Hospitalized patients who had three or more delirium related 
variables had a 60% increased risk of developing delirium,70 yet critically ill patients can be 
subjected to 10 or more of these variables. However, not every ICU patient exposed to 
potential delirium risk factors develops delirium, highlighting the need for delirium research to 
be conducted specifically in the ICU setting.4
Recommendations
The paucity of research that measures both sleep and delirium in the critically ill patient is 
evident. While the theoretical underpinnings may seem strong, the evidence is weak. In going
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forward in this area, several factors should be taken into consideration. Using self-reported sleep 
questionnaires has inherent difficulties when measuring delirium; however, PSG is expensive and 
problematic to initiate in the ICU. Measuring ICU sleep for less than 24 hours is considered a 
limitation due to the amount of daytime sleep found in previous studies. Improved, reliable sleep 
measurement tools such as actinography, bispectral index monitoring (BIS), or portable EEG need to 
be developed and tested. Some studies reported delirium scores from days before and after the one 
time PSG measurement. Any relationship between sleep data and delirium scores should be 
cautiously interpreted. It is well known that at any given time the ICU environment may change 
dramatically in light or noise impacting sleep.39,71-73 The critically ill patients themselves and the 
resulting healthcare interventions can also change significantly from one day to the next. One 24-hour 
period or less of sleep measurement does not reveal a sleep pattern that can be correlated to ongoing 
delirium scores. However, more information is needed on how long sleep disruptions impact patients 
including the development and/or continuation of delirium.
The CAM-ICU delirium instrument has strong psychometrics, yet the use of the ICDSC 
and NEECHAM as continuous delirium variables may be able to better capture the course of 
delirium over time. Additional knowledge is needed regarding whether decreasing high ICDSC or 
NEECHAM delirium positive scores to lower delirium positive scores has patient significance. 
Furthermore, the evidence regarding whether subsyndromal delirium (ICDSD) or mild confusion 
(NEECHAM) are pertinent concepts and their potential impact on patients are in the infancy 
stages.
Delirium and sleep are both multifactorial and can fluctuate considerably even within 24 
hours. Researchers have focused mainly on investigating the magnitude of the delirium or sleep 
disturbances on one day or by averaging the variables across multiple days. Although this research is 
informative, especially in these beginning stages of gathering evidence, there is much
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that can be gained by examining intra-individual variability characterized by delirium 
measurement to delirium measurement over time.68,74 This type of modeling will assist in 
exploring the extent to which important demographic variables such as age, diagnosis, sedation, 
mechanical ventilation, and severity of disease are simultaneously associated with the 
magnitude and day-to-day variability related to sleep and delirium in critically ill patients.
Conclusion
Whether sleep disturbances contribute to delirium or delirium contributes to sleep 
disturbances is debatable.29 In fact, evidence regarding a relationship between sleep and delirium in 
ICU patients is inconclusive. However due to the prevalence and the high cost of delirium to the 
critically ill patient and society as a whole, the theoretical basis for a relationship between sleep 
disturbances and delirium should be addressed. Further research regarding the relationship between 
sleep disturbances and delirium in the critically ill patient is a necessary step toward the development 
and implementation of interventions to prevent delirium and sleep disruption.
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Synopsis
In patients who are critically ill, sleep disturbances may complicate recovery. Sleep is a 
dynamic function that impacts a person’s ability to meets physical and mental needs. Sleep 
deprivation in healthy individuals has been linked to cognitive impairment, depressive mood and poor 
immune response. Neuroimaging studies have shown that sleep deprivation results in decreased 
cerebral metabolism, cerebral blood flow and brain oxygenation. Various sleep measurement 
modalities have been utilized to study sleep in the intensive care unit (ICU) environment including 
polysomnography, the gold standard of sleep measurement. However, obtaining usable PGS data in 
critically ill patients is expensive and it can be challenging to acquire scoreable PSG data. Studies 
employing PSG often have subjects with non-scoreable PSG data. To acquire scorable PSG data, 
researchers may employ extensive inclusion and/or exclusion criteria, limiting the patient population 
studied in relation to sleep in the ICU environment. This paper reviews the use of PSG with critically 
ill patients, considerations in implementing this method of sleep measurement in the ICU and 
challenges to obtaining comprehensive, accurate sleep data. Recommendations for practice and future 
research are proposed.
Keywords: ICU, sleep, sleep measurement, critical illness, polysomnography
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Polysomnography in the Critically Ill Adult
In the intensive care unit (ICU), more than 50% of patients have been reported to suffer 
from sleep disruption (Bijwadia & Ejaz, 2009). Normal sleep architecture consists of two distinct 
phases: nonrapid eye movement (NREM) and rapid eye movement (REM). Normal human sleep 
patterns consist of four to six 90-110 minute periods where NREM and REM alternate in a 
cyclical fashion (Kamdar et al., 2013; Bijwadia & Ejaz, 2009; Hardin, 2009). NREM can be 
divided into three stages: N1, N2, and N3 or slow wave sleep (SWS), each with their own 
characteristics and properties. In the critically ill, total sleep time (TST) for a 24-hour period can 
be adequate, ranging from 7-9 hours, but up to 50% of TST can occur during daylight hours, 
reflecting a significant amount of sleep fragmentation. Sleep fragmentation is characterized by 
short bursts of sleep, resulting in predominance of N1 sleep stage with scant time in restorative 
Stage 3 and REM sleep stages. In a prospective, observational cohort study, mechanically 
ventilated surgical ICU patients were found to have fragmented sleep with abnormal sleep 
architecture (Friese et al., 2007). In these patients, TST averaged 8.25 hours, but 96% of TST 
was spent in stages 1 and 2, 0.29% SWS, and 3.3% REM sleep. Normal sleep architecture in 
healthy adults is distributed as stages 1 and 2, 50% to 60%; SWS, 13% to 23%; and REM sleep, 
20% to 25%. In the ICU patients, sleep was disrupted by multitude of awakenings and arousals. 
It has been observed the amount of sleep fragmentation and overall disturbance varies within 
ICU patients, possibly related to diverse characteristics of critically ill patient populations, ICU 
environments, and disruptions associated with patient care interventions (Hardin, 2009). The 
purpose of this review is to review the use of polysomnography to measure sleep in critically ill 
patients in the ICU setting.
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Consequences of Sleep Deprivation
One of the chief complaints of former ICU patients is sleep deprivation. Qualitative 
research has shown that 54% of ICU patients reported difficulty falling asleep in the ICU settings 
and 26% indicated that the shortness of sleep was a significant burden (Hofhuis et al., 2010). 
Sleep deprivation has been shown to lead to memory deficits and emotional imbalance. When 
sleep is limited to 4 hours per night for numerous nights, the cumulative sleep deprivation can 
lead to impaired attention, critical thinking, reaction time and recall (Maldonado, 2013). 
Disrupted sleep has been associated with weakened immune systems, decreased resistance to 
infection, impaired wound healing, nitrogen imbalance, and negative cardiac, pulmonary, and 
neurological consequences (Bihari, 2012; Hardin, 2009). Sleep deprivation can impair upper 
airway musculature undermining efforts to wean patients from mechanical ventilation and 
weaken the immune system while producing muscle pain, anxiety, and delirium (Celik et al., 
2005). Patients have indicated that the ICU environment disrupts circadian rhythms and disturbs 
sleep, resulting in a lack of sleep (Kiekkas et al., 2010; Fontana & Pittigloi, 2010; Lusk & Lash, 
2005; DeKeyser, 2003; Cornock, 1998). Overall, sleep deprivation may lead to longer ICU 
length of stays and increased mortality (Zhang et al., 2013; Ely et al., 2004). Sleep Measurement 
in the Critically Ill Patient
Accurate sleep measurement that considers the unique characteristics of critically ill 
patients is needed to acquire valid and reliable sleep data that can be used to determine the 
effectiveness of interventions in the ICU setting. The easiest and most cost-effective methods to 
measure sleep are patient self-report and nurse observation. A number of patient self-report sleep 
instruments are widely used to measure sleep among adult populations; however, in ICU patients, 
memory problems related to critical illness, sedation, delirium or dementia are common, and can 
negatively impact validity and reliability of these instruments (Bourne et al., 2007). To use
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patient sleep assessment tools, critically ill patients need to be aware and remember their sleep 
experience. The Richard Campbell Sleep Questionnaire (RCSQ) takes into consideration the 
muscle weakness and difficulty critically ill patients have in maintaining focus by using a short 
visual analog scale. RCSQ strongly correlated with polysomnography (PSG) on sleep depth, 
number of awakenings, percent of time awake and quality of sleep (Richards, O’Sullivan & 
Richards, 2000). RCSQ correlated least well to PSG on the time to fall asleep or sleep latency. 
The lower correlation with sleep latency impacts how well RCSQ measures sleep efficiency or 
the amount of time asleep compared to the time in bed to sleep (Richards et al.,). In the critically 
ill patient who spends considerable time in bed even when not sleeping, sleep latency is as 
valuable a measure of sleep quality. Frisk and Nordstrom (2003) compared patient sleep 
assessment and nurse rated sleep assessment using the RCSQ. There was a strong correlation 
between the patient and nurse completed RCSQ scores. Patients in this study were conscious and 
oriented to place and time. Other studies have determined that assessment tools used by nurses 
to measure sleep time result in over-reporting of total sleep time when compared to PSG 
(Ritmala-Castran et al., 2016, Bourne et al., 2007, Richards, O’Sullivan, & Phillips, 2000). 
Nurses assess patient movement, eye opening, and interactions to determine sleep. Self-report 
and nurse observation depend on patient characteristics to accurately measure sleep. Critically ill 
patients who are not oriented, immobile, or sedated would not be good candidates for either 
method of sleep assessment limiting their usefulness to specific patient populations.
PSG is considered the gold standard for determining the quantity and quality of a patient’s 
sleep. PSG is electroencephalogram (EEG) monitoring with the additional measures of 
electrocardiogram, respiratory effort, pulse oximetry, and various muscle movements. 
Differentiation between wakefulness, Stage 1 and REM sleep is difficult with just EEG (Estrada et 
al., 2006). The addition of electrooculogram (EOG) and chin or limb electromyogram (EMG)
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leads, as part of PSG, allow accurate scoring of these sleep stages. EOG can detect slow eye 
movements that indicate sleep onset and Stage 1 sleep. EOG also detects rapid eye movements 
that distinguish REM sleep from other sleep stages. Rapid eye movements may occur during 
REM sleep and wakefulness, so muscle movements, as measured by EMG leads, are used to 
determine REM sleep. Being awake has the highest level of muscular activity in contrast to REM 
sleep, which has the lowest. PSG is rarely implemented as part of patient care in the ICU related 
to expense, need for trained personnel, and technical challenges. Patient characteristics and the 
ICU environment can interfere with obtaining brain wave recordings that are needed for the
analysis of sleep (Sutter, Stevens, & Kaplan, 2013). Wounds or dressings may interfere with EEG 
electrode placement and the collection of accurate EEG data. EEG artifact may occur from 
patient sweating, muscle activity, and patient movement. Electrical interference can arise from 
common ICU equipment such as mechanical ventilators, pumps and beds (Sutter et al., 2013). 
Loose or dry electrodes can also interfere with EEG recordings and the repair of these 
connections throughout the day and night may in itself interfere with sleep. It is therefore not 
surprising that PSG is rarely implemented as part of patient care in the ICU due to expense, need 
for trained personnel, and these technical challenges.
Due to the expense and challenges of using PSG to measure sleep in the ICU, other 
technological methods have been trialed in various studies. Bispectral index (BIS) monitors brain 
waves provide a measurement of total sleep time (TST), but not sleep time at various sleep stages. 
Lower BIS values could indicate sleep in non-sedated patients (Tung, Lynch, & Roizen, 2002; 
Dahaba et al., 2011); however, neurological trauma, dementia, and delirium can lower BIS values and 
may falsely be interpreted as adding to total sleep time (Bourne, 2007). Another commonly used 
method to measure sleep is actigraphy. An actigraph is a motion-sensing accelerometer than can be 
worn like a wristwatch to record patient movement. Computer algorithms are used to
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translate actigraph data into sleep parameters, associating periods of low activity with sleep and 
high activity with wakefulness. Actigraphy is easy to implement and noninvasive. In general 
populations, actigraphy can be used to measure sleep parameters including TST and number of 
arousals, with high predictive value compared to the gold standard PSG (Weiss et al., 2010; 
Kosmadopoulos et al., 2018). However, actigraphy tends to overestimate sleep by misidentifying 
lack of movement when awake as sleep (Weiss et al. 2010; Kosmadopoulos et al., 2018; Zhu et 
al., 2018). In the critical care setting, actigraphy is less predictive of sleep (Van der Kooi et al., 
2012; Schwab et al. et al., 2018) because within days in a critical care setting, patients can 
develop myopathy (Argov & Latronice, 2015) leading to weakness and reduced motion. Reduced 
motion negatively affects the accuracy of the actigraphy (Bourne, 2007 Van der Kooi et al., 
2012; Schwab et al. et al., 2018). Since actigraphy technology continues to develop and improve 
(Kosmadopoulos et al., 2014), in the future actigraphy may become a more reliable and valid 
option in the ICU to measure sleep.
Sleep measurement in the ICU setting is particularly challenging. The most critically ill 
patients are often sedated, confused or immobile. These patients may be at the most risk of the 
complications related to sleep deprivation, but all these factors are barriers to accurate sleep 
measurement. In general, sleep self-reports, nurse sleep assessments, BIS and actigraphy have 
limitations when compared to PSG, but it is not known if the expense and challenges to use of 
PSG in segments of the critically ill patient population are justified. Examining inclusion and 
exclusion criteria and the amount of usable PSG data in studies that implemented PSG with 
critically ill patients may elucidate the benefits of PSG to obtain sleep data in a diverse 
population of critically ill patients.
While PSG is considered the gold standard for sleep measurement, its use in the ICU setting 
is particularly challenging. The most critically ill patients who are often sedated, confused
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or immobile may be at the most risk of the complications related to sleep deprivation. Yet these 
patients are the most difficult to obtain an accurate sleep measurement. Sleep self- reports, nurse 
sleep assessments, BIS and actigraphy have limitations on reliably measuring sleep in segments 
of the critically ill patient population. However, when the aim is to measure sleep in critically ill 
patients, the benefit of utilizing expensive and challenge ridden PSG to gather valid and reliable 
data is questionable. Examining inclusion and exclusion criteria and the amount of usable PSG 
data in studies that implemented PSG with critically ill patients may determine the benefit of 
PSG to obtain sleep data in a diverse population of critically ill patients.
Methods
Search Strategy
The keywords used in the search strategy were “critical care” or “intensive care unit” 
and “polysomnography”. The search limits were 1) human 2) English language 3) adults and 4) 
year 2000 to present. Articles identified using the keywords in Medline or CINAHL were 
reviewed per inclusion and exclusion criteria. Research articles were required to measure sleep 
by polysomnography in an intensive care unit on critically ill subjects. Review articles and case 
studies were eliminated along with articles utilizing secondary data analysis. The reference list of 
reviews, studies, and editorials were hand searched for additional studies. Titles and abstracts 
were screened in order to assess studies for inclusion according to eligibility criteria.
Results
One hundred and forty-one articles were identified through the database search. A total of 
twenty-six articles met the inclusion criteria. Articles were excluded for the following reasons: not 
relevant to the research question and duplicates. Table 1 summarizes the studies and their relevant 
components. The number of subjects enrolled in the twenty-six studies ranged from nine to seventy. 
The average age of the subjects in the majority of the studies was in their sixth decade.
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In one study, the average age was eighty-two years. Two studies had a younger population 
with an average age in the thirties. In twenty studies, the number of males enrolled was greater 
than females. In two studies, only male subjects were enrolled. The setting for the majority of 
the studies was a general ICU. Eight studies took place in a medical ICU with the rest in 
medical-surgical ICUs, surgical ICU, trauma ICU and a special ventilator weaning unit. PSG 
Data Quality in the Critically Ill Patients
Since 2000, twenty-six studies (See Table 3.1) implemented PSG with adults in the ICU 
setting (Cooper et al., 2000; Freedman et al., 2001; Richards et al., 2002; Gabor et al, 2003; Fanfulla 
et al., 2005; Alexopoulou et al., 2007; Basma et al., 2007; Friese et al., 2007; Toublanc et al., 2007; 
Beecroft et al., 2008; Roche Campo et al., 2010; Trompeo et al., 2011; Koudili et al., 2012; Su et al., 
2012; Andrjak et al., 2013; Cordoba-Izquerdo et al., 2013; Watson et al., 2013; Elliott et al., 2014; 
Knauert et al., 2104; Van den Broecke et al., 2014; Boisen et al., 2016; Ersoy et al., 2016; Wiseman-
Hakes et al., 2016; Boyko et al., 2017; DeMoule et al., 2017., & Huttmann et al., 2017). Sleep in the 
critically ill has been found to be fragmented and occurring throughout a twenty-four-hour period of 
time. Studies using PSG in the ICU setting typically measure sleep during one night. Eight studies 
measured sleep at night for 7-10 hours (Richards et al., 2002.; Fanfula et al., 2005; Bosma et al., 2007; 
Toublanc et al., 2007; Trompeo et al., 2011; Kondili et al., 2012; Audrejak, et al., 2013; Huttmann et 
al., 2017), potentially missing a significant portion of TST. One study gathered data for only two 
hours one night per subject (Su et al., 2012). Four studies used an expanded time frame of 16-18 hours 
for PSG implementation (Roche Campo et al., 2010; Cordoba-Izquerdo et al., 2013; Wiseman-Hakes 
et al., 2016; DeMoule et al., 2017). Some studies realizing the fragmented nature of sleep in the ICU 
environment sleep utilized PSG for 24 hours possibly revealing a more accurate sleep state (Cooper et 
al., 2000, Freedman et al., 2001, Gabor et al., 2003, Alexopoulou et al., 2007; Friese et al., 2007; 
Elliott et al., 2014; Knauert
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et al., 2014; Boisen et al., 2016; Ersoy et al., 2016). Two studies implemented longer PSG times. 
Boyko and colleagues (2017) had 48 hours of PSG per subject. While Watson and colleagues 
(2013) gathered PSG sleep data from 40-72 hours per subject with an average of 54.8 hours. The 
expense and difficulty of implementing PSG in the ICU setting may be the reason only one-half 
of the studies used a 24-hour time frame for data gathering.
48
Table 3.1
Summary of Study Findings
Reference Study Aim Inclusion/ Exclusion Criteria # Enrolled/ Study Design and
Year # Data used in Analysis Intervention
Reason for Discrepancy
Cooper et Measure sleep in Inclusion: ETT, MV >24 hr N=26 Prospective
al. the critically ill on Exclusion: ICU stay <24 hr, 20 analyzed observational
2000 MV unlikely survival, premorbid disease 6 discarded due to artifact
impacts sleep data, hemodynamic
instability, general anesthesia or
drug overdose or alcohol past 24 hrs
Richards et Exam frequency Inclusion: No OSA, N=70 Prospective
al. & severity of hemodynamically stable, 64 analyzed observational
2002 OSA in No severe dysrhythmias, ongoing 6 respiratory artifact
Older, stable men chest pain,
with acute Infrequent pressor changes, <48 hrs
cardiovascular critical
Disease care unit
Gabor et al. Determine impact Inclusion: ETT, MV for next 24 hrs
2003 ICU noise & pt Exclusion :previously published
care activites on exclusion criteria for reliable PSG
sleep continuity (See Cooper et al., 2000)
in critically ill pts
compatred to
healthy volunteers
in the ICU
environment
N= 7 critically ill & 6 Comparative
healthy volunteers prospective
13 analyzed
Reference Study Aim Inclusion/ Exclusion Criteria # Enrolled/ Study Design and
Year # Data used in Analysis Intervention
Reason for Discrepancy
Fanfulla et Compare effects Inclusion: Neuromuscular disorder, N=9 Comparative
al. of 2 ventilation chronic respiratory failure, long 9 analyzed crossover
2005 settings on sleep term NIMV, admitted with clinical 2 NIMV settings
architecture stability
Alexopoulou Determine Inclusions: good patient ventilator N=17 Comparative
et al. whether large synchrony 17 night data analyzed prospective
2007 number of end Large amount unreliable
inspiratory sleep data during
occlusions wakefulness in sedated
influences sleep patients
in speciifrc
ventilator modes
Bosma et al. Understand Inclusion: MV ≥3 days, Intact N=16 Randomized
2007 patient ventilator respiratory drive; Propofol DC 13 analyzed Crossover clinical
asynchromy as minimal 36 hrs; Lorazepam DC 2 sepsis trial
related to sleep minimum 72 hrs.; Morphine ≤0.01 1 hypoxia
disruption mg/kg/hr; Alert; GCS ≥10
& optimizing Exclusion: Spontaneous breathing
patient trial done; Abnormal EEG 24 hrs
ventilator before study; Central sleep apnea;
interaction Drug/alcohol abuse; General
improves sleep anesthesia <72 hrs; Haldol >10
mg/24 hrs, hemodynamically stable,
infection, sepsis
Reference Study Aim Inclusion/ Exclusion Criteria # Enrolled/ Study Design and
Year # Data used in Analysis Intervention
Reason for Discrepancy
Friese et al. Describe quantity Inclusion: ICU LOS ≥2 days; No N=16 Prospective
2007 & quality of sleep general anesthesia >24 hrs; 16 analyzed observational
& sleep Exclusion: Closed head injury; TBI;
architecutre hemodynamically instability; sepsis;
systemic inflammatory response
syndrome; sleep disorder; frequent
surgeries; lorazepam and morphine
equivalents limits
Toublanc et Compare impact Inclusion: Intubated mechanically N=22 Prospective
al. of assist control & ventilated; acute on chronic 20 analyzed randomized
2007 pressure control respiratory failure; 1 electric artifact crossover
ventilation on hemodynamically stable 1 respiratory distress
sleep quality Exclusion: Sedative, narcotic,
analeptic drugs <48 hrs
Beecroft et Evaluate the Inclusion: Unrestrained; MV; vent N=12 Prospective
al. accuracy between setting not changed ≥24 hrs; 12 analyzed observational
2008 PSG, actigraphy Anticipate MV for 48 hrs
& behavioral Exclusion: Unlikely survival <3
assessment by RN mos.; hopeless prognosis;
neurologic & sleep disorders;
hemodynamic stability; GCS ≤10;
Lorazepam & Morphine equivalent
limits
Reference Study Aim Inclusion/ Exclusion Criteria # Enrolled/ Study Design and
Year # Data used in Analysis Intervention
Reason for Discrepancy
Campo et Determine if sleep Inclusion hypercapnic acute-on- N=27 Prospective,
al. quality may chronic respiratory failure treated by 19 analyzed observational
2010 predict NIV NIV, ≥65 yrs, 8 discarded for abnormal
outcomes in Exclusion: encephalopathy, sedative EEG pattern
patients with or opioid, or neuroleptic drugs
acute hypercapnic within 48 hrs, neurologic or
respiratory failure psychiatric disease, hemodynamic
instability.
Trompeo et Assess the Exclusion: abnormal EEG 24 before N=29 Prospective,
al. characteristics of enrollment, anesthesia 72 hr 29 analyzed observational
2011 sleep disruption previously, sepsis, hemodynamic
surgical critically instability
ill patients
examining the
hypothesis that
severe
impairments of
REM sleep are
associated to
delirium
Reference Study Aim Inclusion/ Exclusion Criteria # Enrolled/ Study Design and
Year # Data used in Analysis Intervention
Reason for Discrepancy
Kondili et Assess effect of Inclusion: propofol titrated Ramsey N=12 Randomized
al. propofol on sleep score 3, MV at least 48 hrs, 11 analyzed crossover
2012 quality on vented hemodynamically stable without Ventilator mode change Sedated with
critically ill vasoactive drugs propofol & no
patients Exclusion: Sedation or opioids other sedation
than propofol, GCS <11, APACHE
>15, delirium, epilepsy/neurologic
disease, sleep apnea, sepsis
Su et al. Examine effects Inclusion: ≥18 yrs, APACHE ≤25, N=28 Randomized
2012 of non- conscious & clear 28 analyzed controlled trial
commercial music Exclusion: hearing impaired, Music before
on sleep quality & physical restraint, alcoholism, sleep & no music
relaxation indices infectious disease, hemodynamically
in patients in instability
ICUs
Andrejak et Evaluate the Inclusion: Acute on chronic N=35 Prospective,
al. effect on sleep of respiratory failure, 26 analyzed observational
2013 pressure control Pressure control ventilation, no 5 discarded in-accurate
ventilation encephalopathy, no sedative, opioid, PSG data/excessive
or neuroleptic drugs administered artifact; 4 for no
the last 48 hrs hemodynamically ventilator data
stable
Reference Study Aim Inclusion/ Exclusion Criteria # Enrolled/ Study Design and
Year # Data used in Analysis Intervention
Reason for Discrepancy
Cordoba- Compare sleep Inclusion: Acute hypercapnic N=25 Prospective
Izquerdo et quality between respiratory failure, expected >1 day 24 analyzed randomized study
al. two ventilation NIV 1 technical issues
2013 types Exclusion: Hypercapnic coma,
sleep altering medication, home
treatment with NIV or continuous
positive airway pressure, central
neurologic disease, hemodynamic
instability
Watson et Quantify typical Inclusion: >18 yrs, expected >24 hrs N=37 Prospective
al. & atypical PSG in MV 37 analyzed observational
2013 critically ill Exclusion: Psychosis, anoxic brain 36 atypical sleep (85% all
patients to injury, stroke, subdural hematoma, recorded data) not
develop & neurotrauma, cirrhosis analyzable by standard
reliability test methods
methodology
characterizing
atypical PSG
Elliott et al Describe intrinsic Inclusion: >17 yrs, ICU stay >24 hrs N=57 Prospective
2014 and extrinsic Exclusion: sleep disorder, 53 analyzed observational
factors affecting psychiatric illness, dementia, drug 2 request end PSG
sleep in critically or alcohol withdrawal, central 1 palliative care
ill patients & neurologic impairment 1 unable to analyze
examine potential
Reference Study Aim Inclusion/ Exclusion Criteria # Enrolled/ Study Design and
Year # Data used in Analysis Intervention
Reason for Discrepancy
relationships with
sleep quality
Van den Assess feasibility Inclusion: ≥18 age, acute coronary N=27 Prospective
Broecke et of sleep- syndrome 27 analyzed observational
al. disordered Exclusion: Sleep breathing disorder,
2014 breathing at early hemodynamic instability, acute
phase acute heart failure, unable to provide
coronary consent
syndrome
Boesen et al. Assess sleep Inclusion: MV; ≥18 yrs age; no N=14 Observational
2016 quality by PSG in structural illness 14 analyzed Study
relation to Exclusion: Propofol & 1 intermittent electrode
delirium in MV benzodiazepine malfunction;
nonsedated 1 PSG lost 4 hours
patinets
Wiseman- Determine Inclusion: GCS 3-8 in ER & 30 N=15 Cross sectional
Hakes et al. feasibility using minutes later, Age 16-59 yrs, 13 analyzed case control
2016 PSG in ICU extubated; normal ICP, no infection, 1 unable to analyzed
patients with TBI continuous IV sedation & analgesia 1 not tolerated
off >48 hrs.
Exclusion: Previous psychiatric or
neurology disorder, sleep disorder,
substance abuse, disease impacts
sleep, pregnancy, severe eye injury,
skull bone flap removal
Reference Study Aim Inclusion/ Exclusion Criteria # Enrolled/ Study Design and
Year # Data used in Analysis Intervention
Reason for Discrepancy
Boyko et al. Compare sleep in Inclusion: Expected MV >48 hrs, N=13 Random
2017 nondelirious ICU Exclusion: Comatose, delirium, 13 analyzed controlled trial
patients on MV acute intracerebral events, 8% recording total time cross over design
during “quiet circulatory shock had artifact
routine” night &
usual night
DeMoule et Determine the Inclusion: No sedation >24 hrs, RSS N=64 Prospective
al. impact of ear <3, expected ICU stay >48 hrs, 42 analyzed randomized study
2017 plugs & eye morphine <0.01 mg/kg/min, 3 withdrew
masks on norepinephrine <0.3 µg/kg/minute 10 poor signal quality
critically ill Exclusion: History sleep disorders, 9 unable to interpret
patients’ sleep medicated psychiatric illness,
central neurological impairment,
liver disease encephalopathy,
uncontrolled sepsis, severe hearing
impairment or blindness
Huttmann Assess sleep Inclusion: Tracheotomy, fully N=21 Prospective
et al. quality in conscious, stable state, no clinical 19 analyzed observational
2017 critically ill signs sepsis, meet criteria to wean 2 discarded PSG Study
patients Exclusion: Vasopressors, continuous technology limits
receiveing IMV sedation, anxiolytics, analgesics,
on weaning unit delirium
PSG polysomnography; MV mechanical ventilation; ETT endotracheal tube, ICU intensive care unit, NIV non-invasive ventilation, IMV invasive mechanical 
ventilation; REM rapid eye movement, GCS Glascow Coma Scale, TST total sleep time, RSS Ramsey Sedation Scale, TBI traumatic brain injury, OSA Obstructive 
Sleep Apnea, IV intravenous, hrs hours, PT patient; NIMW non-invasive mechanical ventilation; DC discontinue; EEG electroencephalogram; LOS length of stay; 
emergency room; ICP intracranial pressure
Barriers to Using Full PSG Data
Eighteen of the twenty-six studies were not able to use or complete the PSG data for all 
of their subjects. Beyond the two studies with PSG lasting longer than 48 hours, the studies with 
the shortest observation times had the highest percentages of usable data. Only four studies had 
PSG for 16-18 hours with 67% of the subject’s data used. Four of the studies with 24-hour PSG 
were able to use all the data: however, overall only 86.8% of subject’s data were included in 
analysis. It may be that the longer the duration of the frame required for PSG, the more likely data 
will not be available for analysis. The two studies with the longest PSG intervals used all the 
enrolled subjects’ sleep data. However, Boyko and colleagues (2017) reported that the PSG data 
had eight percent artifact. Watson and colleagues (2013) stated that eighty-five percent of all the 
recorded sleep data was atypical. This study was developing and exploring the reliability of a 
method to measure atypical sleep patterns. In other studies, the artifact and atypical sleep may 
have resulted in discarded data. Alexopoulou and colleagues (2007) used all their subjects’ PSG 
data but did report a large amount of unreliable sleep data during wakefulness in sedated subjects. 
So the longer the interval of PSG, the more likely it seems that PSG data may be compromised, 
however, the standards used to determine what data is used or discarded is not clearly articulated.
The stated reasons for incomplete data included artifact, abnormal PSG, inaccurate 
PSG, missed ventilator data, respiratory distress, hypoxia, sepsis, subjects’ withdrawal, poor 
signal quality and technology limits. A total of nine subjects withdrew or were withdrawn from 
five studies had after enrollment (Toublanc et al., 2007; Elliott et al., 2014; Knauert et al., 2014; 
DuMoule et al., 2017; Wiseman-Hakes et al., 2016). Elliott and colleagues (2014) had a total of 
three subjects withdraw from their study. One subject withdrew due to a transition to palliative 
care. No additional reasons for withdrawal were identified for five additional subjects
withdrawing from the Elliott et al. (2014) and DuMoule et al. (2017) studies. Other reasons for
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withdrawal include not tolerating PSG, respiratory distress, and patient deterioration. Some 
subjects may find the multiple electrodes uncomfortable and end their participation in the study. 
Additionally, if the signal quality is monitored throughout PSG, technicians may interrupt rest to 
reduce poor signal quality and artifact which could be a dissatisfier for subjects. Five studies had 
multiple subjects with unusable data due to artifact or poor signal quality (Cooper et al., 2000; 
Richards et al., 2002; Andrejak et al., 2013; Ersoy et al., 2016; DeMoule et al., 2017). Cooper et 
al. (2000) lost data from 6 out of 26 subjects due to artifact. Electrical artifact, technical problems 
and severe respiratory artifact were the reasons indicated for unused PSG data. The patients with 
severe respiratory artifact were also considered very edematous which may impact the quality of 
the PSG data. Andrejak et al. (2013) enrolled 35 subjects and data from six of those subjects was 
not used due to inaccurate PSG and/or excessive artifact. Additionally, DuMoule and colleagues 
(2017) missed data from ten out of 64 subjects due to poor signal quality. Artifact and poor signal 
quality can be related to ICU equipment, dressings, edema, diaphoresis, and electrode connection. 
Three of the studies impacted by artifact gathered PSG data from sixteen to forty-eight hours. 
One study collected sleep data for 48 hours and while no subject’s data were discarded, eight 
percent of the total recording was artifact. The longer the study, the more important it seems the 
monitoring of the electrode signal to reduce artifact.
Although monitoring the electrode signal may reduce artifact, the use of a technician to 
monitor the signal is an added PSG expense that does not guarantee a complete reduction in 
artifact issues. Knauert and colleagues (2014) gathered sleep data for 24 hours per subject using 
a portable PSG in a medical ICU. No attendant monitored the PSG during the study and 
interpretable data was collected from 27 subjects out of the 29 enrolled. None of the data was 
affected by electrical artifact. Yet only one subject had a full 24 hours of data. Eight subjects had 
18-24 hours of PSG data. Three had 6-12 hours and four had less than 4 hours of sleep data.
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Having an attendant may have resulted in less truncated data. Future researchers may decide 
to utilize attendants based on the length of PSG sleep measurement and attendant expense.
Investigators were also not able to analyze data due to abnormal PSG information. The 
inability to interpret PSG data due to abnormal brain waves was present in eight different studies 
(Freedman et al., 2001; Alexopoulou et al.; 2007; Roche Campo et al., 2010; Elliott et al., 2014; 
Knauert et al., 2014; Wise-Hakes et al., 2016; DuMoule et al.; 2017; Huttmann et al., 2017). Two 
of these studies had over twenty percent of their data discarded related to atypical sleep or brain 
waves (Freedman et al., 2001; Roche Campo et al., 2010). Freedman and colleagues (2001) 
reported that PSG data from five subjects were not able to be analyzed due abnormal brain waves 
related to septic encephalopathy. EEG of patients with encephalopathy may show abnormal 
diffuse ongoing slow waves without sleep architecture (Kavanau, 2005). While Alexopoulou and 
colleagues (2007) had sleep data from during the night, the day sleep data from sedated subjects 
was unreliable.
Instead of analyzing abnormal EEG, Watson and colleagues (2013) explored developing 
a methodology to characterize atypical sleep in mechanically ventilated critically ill patients. In 
their study, thirty-six of thirty-seven subjects had atypical sleep. Eighty-five percent of all 
recorded data was not analyzable by standard methods like Rechtschaffen and Kales’ sleep 
criteria or the American Academy of Sleep Medicine scoring standards. Eleven studies were able 
to utilize some PSG data from every subject in their analysis (Gabor et al., 2003; Fanfulla et al., 
2005; Alexopoulou et al., 2007; Friese et al., 2007; Beecroft et al, 2008; Trompeo et al., 2011; Su 
et al., 2012; Watson et al., 2013; Van den Broecke et al., 2014; Boyko et al., 2017). However, 
some studies still included a subject’s data even if part of the data was not usable for various 
reasons such as intermittent artifact or abnormal data (Alexopoulou et al., 2007; Watson et al., 
2013; Boesen et al., 2016; Boyko et al., 2017). Certain medications are known to impact sleep
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architecture leading to abnormal sleep (Oldham & Pisani, 2015). Benzodiazepines increase sleep 
efficiency but suppress REM and decrease slow wave sleep. Opioids also suppress REM and may 
lead to central sleep apnea. While in higher doses of propofol leads to a burst suppression brain wave 
pattern without the common sleep architecture elements. Only three of the studies including data from 
every subject had inclusion or exclusion data that specifically limited sedation, opioids or propofol. 
Two studies had parameters of no delirium and conscious/clear that lead to a limit to certain 
medications ( Su et al., 2012; Boyko et al., 2017). However, benzodiazepine, opioid and propofol 
limitation does not seem to be a consistent contributor to analyzable sleep architecture.
Respiratory failure was the most common primary diagnosis in the studies able to use 
data from every subject. In two studies, all the subjects had respiratory diagnoses: acute 
respiratory failure secondary to surgical procedures (Trompeo et al., 2011) and chronic 
respiratory failure due to neuromuscular disease (Fanfulla et al., 2005). Gabor et al. (2003) 
described their patient population as having respiratory insufficiency or multiple trauma. More 
than half of the subjects were diagnosed with acute respiratory failure in the Cabello et al. 
(2008) study. The rest of the subjects had cardiac surgery, abdominal surgery or sepsis.
In the studies that were not able to use the data from all the enrolled patients, multiple 
diagnoses were identified. Some studies focused on specific diagnosis such as mild or moderate 
lung injury (Cooper et al., 2000), hypercapnia (Roche Campo et al., 2010), and acute on chronic 
respiratory failure (Andrejak et al., 2013; Cordoba-Izquerdo et al., 2013). Within other studies, 
subjects had various diagnoses. In the Freedman and colleagues (2001) study, the subjects had 
diagnoses of pneumonia, sepsis, chronic obstructive pulmonary disease, and acute respiratory 
distress syndrome. The Alexopoulou et al. (2007) study identified sepsis abdominal aorta aneurysm 
rupture, heart failure, pneumonia, cardiogenic shock and spinal cord injury as subject
diagnoses. The DeMoule and colleague study (2017) reported diagnoses of acute respiratory
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failure, pneumonia, chronic respiratory failure, sepsis, metabolic issues, trauma, neuromuscular 
disease and vascular disease. A number of studies that were unable to use all the PSG data 
identified no specific subject diagnoses (Kondili et al., 2012; Su et al., 2012; Elliott et al., 2014; 
Ritmala-Castran, 2016; Huttmann et al., 2017). Due to the wide variety of diagnoses or lack of 
diagnoses identified in studies, making an association between complete PSG data and 
diagnoses impossible.
Of particular interest, Wiseman-Hakes and colleagues (2016) is the only study to explore 
sleep in patients with a primary neurologic brain diagnosis. Often neurologic diagnoses are 
excluded in sleep studies due to the possible impact on brain waves. This study enrolled fifteen 
subjects and only one had PSG data that was not able to be analyzed. These subjects were 
extubated, had normal intracranial pressure and were off continuous intravenous sedation and 
analgesia for greater than forty-eight hours. These parameters may have contributed to the 
amount of usable data. In all the other studies, only two enrolled patients with a central 
neurologic injury. Alexopoulou et al. (2007) enrolled one subject with central nervous system 
damage and was able to obtain usable PSG data. With the other study the ability to use the data 
from the neurologic patient is unable to be discerned (Knauert et al., 2014). Particular diagnoses 
may or may not impact the ability to obtain usable PSG data. However, many acute diagnoses 
particularly neurologic have not been studied in relation to sleep architecture in the critically ill 
patient.
Mechanical Ventilation
Mechanical ventilation may not in itself interfere with the ability to acquire accurate PSG 
data. In eighteen of the studies, all the included patients were mechanically ventilated (Cooper et 
al., 2000; Gabor et al., 2003; Fanfula et al., 2005; Alexopoulou et al., 2007; Bosma et al., 2007; 
Toublanc et al., 2007; Beecroft et al., 2008; Cabello et al., 2008; Roche Campo et al., 2010;
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Trompeo et al., 2011; Kondili et al., 2012; Anderjak et al., 2013; Cordoba-Izquerdo et al., 2013; 
Watson et al., 2013; Boesen et al., 2016; Ersoy et al., 2016; Boyko et al., 2017; Huttmann et al., 
2017). Nine of these studies were able to use the PSG data from all the enrolled patients, 
possibly related to their inclusion and exclusion criteria (Gabor et al., 2003; Fanfulla et al., 2005; 
Alexopoulou et al., 2007; Beecroft et al., 2008; Cabello et al., 2008; Trompeo et al., 2011; 
Watson et al., 2013; Boesen et al., 2016; Boyko et al., 2017). In contrast, Roche Campo and 
colleagues (2010) were only able to use PSG data from 19 out the 27 mechanically ventilated 
enrolled subjects. Five studies comparing pressure-controlled ventilation to pressure support 
ventilation effects on sleep were not able to use the data from all the enrolled patients (Elliot et 
al., 2014; Andrejak et al., 2013; Roche Campo et al., 2010; Freedman et al., 2001; Cooper et al., 
2000). Mechanically ventilated patients are some of the most studied related to critically ill sleep 
and may be why researchers have been able to learn methods to gather usable sleep data.
Discussion
With the omission of up to 60% of PSG data in the analysis, researchers may use inclusion 
and exclusion criteria to increase the probability that the PSG will be scorable. Sample exclusion 
criteria used by the studies able to utilize all the PSG data include: sedation in the previous 24 hours, 
opioids for 24 hours, neuroleptic medications, general anesthesia for 24 hours, neurologic diagnosis, 
epilepsy, delirium, Glasgow Coma Scale <10 or 11, hemodynamic instability, sepsis, Apache II scale 
>15, encephalopathy, drug overdose, anticipated death, psychiatric diagnosis, sleep apnea, and 
ventilator dyssynchrony with ineffective effort and apnea. The ICU sleep knowledge gained in these 
studies may not pertain to the most critically ill patients who may not have the physical resources to 
deal with the further stress of sleep deprivation.
Extensive exclusion criteria may not be the only available method to insure the ability to
analyze the PSG data from all enrolled patients. Trompeo et al. (2011) conducted a study to
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assess the characteristics of sleep disruption in a cohort of surgical critically ill patients who 
developed acute respiratory failure with the hypothesis that severe impairments of rapid eye 
movement sleep are associated with delirium. Before initiating PSG, the subjects needed to 
meet strict ventilator weaning readiness requirements. Additionally, the patients would be 
excluded or PSG not initiated for: sedation or analgesia within 24 hours, GCS <10, stroke, 
hemodynamic instability, general anesthesia in the past 72 hours, alcohol or drug withdrawal, 
psychosis, Alzheimer’s, dementia, mental retardation, and Parkinson disease. Along with this 
extensive list of criteria, PSG was not performed if patients had an EEG in the previous 24 
hours which determined to be “abnormal” with nonspecific slowing and/or residual drug effects 
(Trompeo et al., 2010). Information was not divulged regarding how many potential subjects 
were excluded related to an abnormal EEG. This study was able to use the PSG data from all 29 
of its enrolled subjects. It is unknown whether all the PSG data was included in the analysis due 
to the comprehensive inclusion/exclusion criteria or the pre-screening EEG before PSG 
placement. However, having information regarding a potential subject’s EEG may eliminate the 
need for extensive inclusion or exclusion criteria and allow subjects who may have been 
excluded to be studied; thereby possibly expanding ICU sleep information to a wider patient 
population. Converting Continuous EEG to PSG
Continuous electroencephalography monitoring (cEEG) could be implemented to pre-
screen for the presence of normal brain waves and sleep architecture and then can easily be 
converted to PSG. This may limit unusable data due abnormal brain waves and limit expense 
by converting a ordered diagnostic procedure to PSG. Continuous EEG provides physiologic 
information regarding brain function, particularly in unresponsive patients (Oddo et al., 2009). 
Continuous EEG can be converted to PSG by adding components such as EOG and EMG 
electrodes. In the sleep laboratory setting, video-EEG PSG is used to diagnose nocturnal events
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with complex behavior and movements as possible sleep or seizure in origin (Kryger, Roth, & 
Dement, 2005). Converting EEG to PSG is less expensive that implementing PSG in the ICU 
environment. Digital computer software to analyze EEG data would have to be expanded to be 
able to also analyze sleep architecture. Unfortunately, patients who have EEG order as part of 
their ordered care may have abnormal brain waves that obliterates normal sleep architecture. 
Drouot et al. (2011) and Cooper et al. (2000) found ICU patients without conventional sleep 
markers. Patients had atypical sleep with or without pathological wakefulness. Atypical sleep had 
no Stage 2 markers, minimal REM and slow background reactivity. Pathological wakefulness 
consisted of impaired reactivity on EEG to stimulus. As patients with ordered EEG are more 
likely to have some level of brain dysfunction, they have a greater risk of exhibiting atypical 
sleep. The implications on patient outcomes related to atypical brain wave patterns in patients 
who are not exhibiting sleep architecture is not clear. Further studies examining a possible 
relationship between no sleep architecture and patient outcomes such as hospital and ICU length 
of stay, mechanical ventilation days, morbidity, and mortality are needed. Additionally, using 
continuous EEG to determine if sleep architecture can be analyzed may allow researchers to 
study sleep in patient populations normally excluded from ICU sleep studies. Furthermore, the 
advance screening of brain waves for sleep architecture by c(EEG) can mitigate the expense of 
initiating PSG and obtaining unusable sleep data.
While using cEEG to screen critically ill subjects for sleep studies may insure complete PSG 
data, patients with cEEG ordered as part of their plan of care may have brain wave anomalies. 
Critically ill patients often suffer from an alteration of mental status. Continuous EEG can be used to 
evaluate those changes. Most abnormal EEG activity will have certain patterns: 1) epileptiform, 2) 
slow waves, 3) amplitude abnormalities and 4) deviations from normal (Weinhous, 2009; Buzea, 
1995). Epileptiform activity is related to irritable areas of the cerebral
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cortex that occurs with seizures-subclinical or otherwise (Sutter, Stevens & Kaplan, 2013; Oddo 
et al., 2009, Buzea, 1995). Brain damage related to acute or chronic lesions due to stroke, trauma, 
hemorrhages, tumor, and scar tissue from older injuries can all produce types of epileptiform 
discharges (Andraus, Andraus, & Alves-Leon, 2012). Generalized epileptiform activity found in 
both brain hemispheres are often related to metabolic disturbances or toxic agents, anoxic brain 
injury, and central nervous system infection (Andraus, Andraus, & Alves-Leon, 2012; Buzea, 
1995). Slow waves have less than 8 Hz frequency and can be found in a focal area or generalized. 
Focal slow waves are associated with cerebral cortex damage related to tumors, infarcts, 
hemorrhages, abscesses or temporary events like transient ischemic attacks, migraines or partial 
seizures (Buzea, 1995). Generalized slow waves are normal during sleep, but abnormal during 
wakefulness. Wakeful slow waves can be seen with dementia, demyelinating disease, 
encephalitis and infections. Burst suppression is a brain wave pattern where high voltage burst 
activity alternates with flatline suppression activity (Ching et al., 2011; Wang & Agarwal, 2007). 
Burst suppression can be caused by toxic and metabolic disorders, sedation medications such as 
propofol and benzodiazepines, hypothermia and coma (Ching et al., 2011; Murphy et al., 2011; 
Weinhous, 2009; Buzea, 1995). The multiple possible brain wave disturbances that may interfere 
with PSG in critically ill patients accounts for the often extensive inclusion and exclusion criteria 
in ICU sleep studies.
Conclusions
Measuring sleep in the ICU environment is challenging. To obtain the most accurate 
and comprehensive sleep data, PSG is recommended. However, PSG is expensive and difficult 
to implement in critically ill patients. The loss of PSG data due to its inability to be analyzed can 
cause researchers to implement inclusion and exclusion criteria to try to guarantee usable EEG 
data, but excludes many typical ICU patients. Using EEG to pre-screen patients for sleep
65
architecture and converting continuous EEG to PSG may expand the ICU patient populations 
studied related to sleep architecture. By determining additional methods to accurately 
measure sleep, further knowledge regarding the impact of sleep disruption in the critically ill 
may be discovered.
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Synopsis
Background: Sleep is a complex process essential for the optimization of functioning. The
absence of sleep in critically ill patients may potentially have negative consequences. 
Objectives: Presence or absence of sleep architecture (SA) per continuous 
electroencephalogram (cEEG) monitoring and outcomes in critically ill patients were explored 
and factors associated with absence of SA were identified.
Methods: Retrospective chart reviews was determined the presence or absence of 
documented SA in patients who had cEEG as part of their care.
Results: Records (N=84) indicated that 61 patients had no SA over Days 1 to 2 of monitoring 
and 50 over Days 1 to 5 of monitoring. Propofol was associated with no SA during Days 1 to 2. 
Abnormal creatinine, adjusted for neurologic physiologic state, age and medications, showed an 
association with no SA Days 1 to 2 (OR 4.35, 95% C.I. 1.15-16.45, p=0.031). No SA Days 1 to 2 
was associated with increased ICU length of stay (LOS), days of mechanical ventilation, hospital 
LOS and patient destination post-hospitalization.
Conclusions: This study supports sleep as an important part of critically ill patients’
outcomes/recovery. More research is needed to guide practice and develop evidence-based 
sleep interventions.
Keywords: Sleep Architecture, electroencephalogram (EEG), outcomes, intensive care
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Sleep Architecture of Patients in Intensive Care and Patient Outcomes
Introduction
Sleep is a complex process with physiologic, behavioral and brain wave components 
essential for the optimization of cognitive, mood and physiologic functions (Kamdar, Needham,
& Collop, 2012; Hardin, 2009). Sleep in critically patients often does not follow typical 
processes or sleep phases, potentially leading to negative patient consequences. Sleep normally 
cycles between nonrapid eye movement (NREM) and rapid eye movement (REM) stages. NREM 
consists of three distinct phases: N1, N2, and N3 or slow wave sleep (SWS). Normal sleep 
architecture will cycle through NREM and REM stages over 90-100 minutes four to six times per 
night. However, patients in the intensive care unit (ICU) have been found to have significant 
variation from normal sleep architecture (Pisani et al., 2015).
Sleep deprivation can be characterized by decreased total sleep time (TST), difficulty 
falling asleep (sleep latency), staying asleep (sleep efficiency), multiple arousals, and multiple 
short sleep episodes (sleep fragmentation). Up to fifty percent of critically ill patients have 
reported sleep disturbances during their ICU stay (Bijwadia & Ejaz, 2009). While critically ill 
patients often have a normal TST, a large portion of that sleep occurs during day hours. Their 
sleep is exemplified by poor sleep efficiency with multiple arousals and fragmentation. Sleep 
fragmentation consists of brief spurts of sleep, resulting in primarily N1 sleep stage with minimal 
time in restorative SWS and REM sleep stages. Friese and colleagues (2007) found that 
mechanically ventilated surgical ICU patients had fragmented, abnormal sleep architecture. Their 
TST averaged 8.25 hours, but 96% of TST was in stages 1 and 2, 0.29% SWS, and 3.3% REM 
sleep. Healthy adults’ normal sleep architecture consists of stages 1 and 2, 50% to 60% sleep 
time; SWS, 13% to 23%; and REM sleep, 20% to 25%.
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Sleep as a physiological activity repairs and restores the body. Sleep disturbances have 
been found to increase the risk of hypertension (Fernandez-Mendoza et al., 2012; Vgontzas et al.,
2009), impair insulin metabolism (Spiegel et al., 2005; Strand et al., 2015), weaken pulmonary
mechanics (Chen & Tang, 1989; Series, Roy & Marc, 1994; Tadjalli & Peever, 2010), delay 
wound healing (Lange, Dimitrov & Born, 2018; Wright et al., 2015), decrease the immune 
response (Lange et al., 2003; Faraut et al., 2012) and adverse psychological and neurological 
processes (Anderson et al., 2018; Banks & Dinges, 2007; Trautmann et al., 2018; Tucker et al., 
2010). Impaired sleep increases the sympathetic nervous system response, resulting in the 
increased release of epinephrine and norepinephrine and the suppression of insulin. These 
physiologic changes result in increased heart rate and blood pressure along with impaired 
glucose metabolism (Joo et al., 2012; Takase et al., 2004). The psychological and neurocognition 
complications can lead to anxiety, depression, irritability, and a decreased pain threshold.
As an additional stressor in patients already impacted by critical illness, disrupted sleep 
may be a potential impediment to successful recovery and outcomes. Sleep disturbances in 
critically ill patients may lead to increased morbidity and mortality. Overall, impaired sleep may 
result in negative patient outcomes such as prolonged mechanical ventilation, ICU time, and 
hospital days. These negative patient outcomes can lead to a change in patients’ transfer locations 
post discharge that are different from their prehospitalization places of residency.
Determining whether sleep disturbances exist in critically ill individuals can be difficult 
in the ICU setting. Polysomnography (PSG), considered the gold standard of sleep measurement, 
integrates brain wave analysis, eye and muscle movements to determine the amount of sleep in 
various sleep stages. Normally, sleep progresses through the non-rapid eye movement stages into 
rapid eye movement sleep. The slow wave and rapid eye movement sleep stages are the most
restorative. Polysomnography distinguishes between stage 1 and rapid eye movement sleep stages 
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by using eye movement and muscle movement electrodes. Stage 1 is light sleep moving from 
wakefulness to sleep and is not known for its restorative properties. Electroencephalography 
(EEG) or continuous EEG (cEEG) is able to distinguish stage 2 and stage 3 or slow wave sleep 
without the electrooculography (EOG) and electromyography (EMG) electrodes. These stages 
progress through to REM sleep. cEEG can determine if sleep has progressed past the initial 
sleep level towards more restorative sleep levels. While polysomnography is expensive and 
difficult to maintain in the ICU environment, cEEG monitoring is often implemented with 
critically ill patients. cEEG would not be able to determine the length of sleep time or the 
amount of time in stage 1 or REM sleep. However, cEEG monitoring can be used to determine 
if normal sleep architecture is present beyond stage 1.
More information on the relevance of sleep disturbances on critically ill patient outcomes is 
needed. The purpose of this study is to explore the potential relationship between the presence or 
absence of sleep architecture per cEEG monitoring and outcomes in critically ill patients.
Additionally, factors that may be related to the presence or absence of sleep in critically 
ill patients per cEEG monitoring are explored.
Methods
This secondary data analysis used data from a retrospective chart review of patients who had 
cEEG ordered as part of their plan of care between April 2015 and January 2016. The original study 
explored the effect of white noise on the sleep of critically ill patients. The findings of cEEG were 
used to pre-screen patients for any sleep architecture and if sleep architecture was observed, then 
patients were recruited for the white noise study. The cEEG findings unexpectedly showed that very 
few patients had sleep architecture. The study was consequently revised to a retrospective chart 
review to gather data about sleep architecture and possible factors that may be related to the presence 
or absence of sleep in critically ill patients. Chart reviews of 84 patients
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who had received care in a single neurologic/medical/surgical intensive care unit in the 
Midwest were included in analyses. Data were collected each day that the patient had cEEG 
while in the ICU. Patients were excluded if a phenobarbital infusion was ordered because of its 
effects on cEEG (Dubey, Kalita, & Misra, 2017).
Design
A retrospective and longitudinal exploratory study design was used to address the 
study aims of this secondary data analysis.
Measures
Based on a review of the literature, potential predictor variables (factors potentially 
related to the presence or absence of sleep architecture) were recorded from the electronic 
health record. Baseline demographic data included gender, age, race, and ethnicity.
Sleep Architecture. Data documenting the presence or absence of sleep architecture were
obtained from the electronic health record notes of the epilepsy physician group who ordered the 
cEEG. The cEEG used a 10-12 electrode system. Continuous EEG is able to capture/recognize sleep 
stages 2 with the characteristic sleep spindles and k complexes and stage 3 slow wave sleep. Stage 1 
and REM sleep cannot be definitively differentiated from each other using cEEG without electrodes to 
measure eye and muscle movement. A patient was determined to have the presence of sleep 
architecture if any sleep stage was identified at any time during cEEG monitoring. In this exploratory 
study, sleep data were grouped into categories of data for 1-2 days (Days 1 to 2) and data from days 1 
to 5 days (Days 1 to 5). These data groupings were not mutually exclusive. The category of sleep data 
from Days 1 to 5 included data from patients with sleep data from Days 1 to 2 and, additionally, days 
3, 4 and 5. This category explores the effect the presence or absence of sleep architecture over a 
longer period of time while keeping the power of a small study size.
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A day of sleep data corresponds to a single day, although the day may not comprise the data for 
the full 24 hours.
Primary Diagnosis Category. The primary patient diagnosis was categorized into one 
of the following groups: Neurologic, Respiratory, Medical, Cardiac, Infections and Substance 
Abuse.
Severity of Illness. The severity of illness was measured by the Acute Physiology, Age,
Chronic Health Evaluation (APACHE) III score (Knaus et al., 1991). The PI calculated the 
APACHE III score (range 0-71) at the time of the chart review using the values from within the 
first 24 hours of the ICU admission. The greater the APACHE III score, the more severe the 
illness is considered. Some subjects did not have the elements needed to calculate the 
APACHE II score, thus the score was not included in logistic regression models.
Physiologic State. Patient subjects were identified as belonging to a physiologic 
state category if they had a primary or secondary diagnosis or comorbidity written in their 
medical record related to the category. Patients could have more than one physiologic state. 
The categories included: Neurology, nephrology, hepatic, infection, sepsis, anoxia, alcohol 
abuse, drug abuse, dementia, cancer, encephalopathy, developmental disability, and seizure.
Lab Values. Serum lab value results were obtained while patients were being monitored
by cEEG and recorded as “normal” or “abnormal;” including both high or low values. Due to the 
limited number of subjects, lab values were considered as a potential predictor variable for sleep 
architecture only if all subjects had the same lab ordered and results obtained. These labs 
included serum levels of sodium, potassium, and creatinine.
Medications. Opioid and benzodiazepines medications were converted to Morphine and
Ativan equivalents using online calculators (Equivalent Opioid Calculator, 2017; Equivalent 
Benzodiazepine Calculator, 2017) and recorded daily on the days patients had cEEG measured.
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Median values of Propofol along with Morphine and Ativan equivalents were calculated with 
the 25th-75th interquartile. Propofol, Morphine equivalents and Ativan equivalents were placed 
into dosage groups. Morphine equivalent was grouped as none, <40mg, and ≥40 mg. Ativan 
equivalent was grouped as none, < 2mg, and ≥2 mg. Propofol was placed into dosage groups of 
none, <2500 mcg, and ≥2500mcg. The dosage groupings of these medications were used in 
statistical models. Due to the small number of patients administered Dexmedetomidine, the 
medication was measured as none or used.
Outcomes. Mechanical ventilation days were measured from day of intubation to day of
extubation, or death. Hospital length of stay was calculated as the time from admission to the 
hospital to discharge or death. ICU length of stay was calculated as the number of days from ICU 
admission to ICU discharge or death. Discharge destination from the hospital (e.g., home, 
nursing home, transitional care) was also recorded.
Ethical Considerations
The parent study protocol and secondary analyses were approved by the institutional 
review board (IRB) of the large Midwestern tertiary care center, and the university with which 
the principal investigator was affiliated.
Statistical Analysis
Data analyses were conducted with SAS version 9.4 (SAS Institute, 2018). All data were 
analyzed descriptively using univariate statistics (e.g., medians, means), and bi-variate statistics such 
as Fisher Exact tests or independent t-tests; Mann Whitney U tests or Chi2 tests. Tests were 
considered statistically significant at p<0.05. There were no corrections made for multiple statistical 
tests. Multiple regression models were developed using influential factors from bi-variate analyses 
(p<0.2) or chosen because of clinical relevance. Candidate factors for logistic
regression models were selected if they were associated with the outcome using p<0.2 in bi-
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variate analyses, and if there was at minimum one subject in both the sleep architecture and 
no sleep architecture categories.
Results
Demographic and Medical Characteristics
Overall characteristics. The average age of the 84 subjects was 53.8 years; 50% were
male. The most prevalent race was Caucasian (85%). Other races represented included Black 
(10%), Asian (4%), and American Indian/Alaskan Native (2%). By far, the most common 
primary diagnosis was neurologic in nature (68%). A neurologic physiologic state was the most 
prevalent with 62% of the subjects having this secondary diagnosis or comorbidity. The next two 
common physiologic states were infection (35%) and encephalopathy (33%). (See Table 4.1).
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Table 4.1
Demographic and Medical Characteristics Overall and by Presence or Absence of Sleep Architecture Grouped Days 1 to 2 and Days 1 to 5
Variable Overall SA on Day No SA on Day P value SA on Day No SA on Day
1 to 2 1 to 2 1 to 5 1 to 5
N 84 23 61 34 50
Age in years, mean (SD) 53.8 (19.1) 47.4 (19.3) 56.2 (18.6) 0.060 50.0 (19.5) 56.3 (18.6)
Male sex, n(%) 42 (50) 11 (48) 31 (51) 0.807 17 (50) 25 (50)
Apache III,* mean (SD) 62.0 (26.5) 44.1 (23.6) 68.8 (24.5) <.001 51.5 (28.5) 689.2 (22.8)
Race
71 (85) 18 (78) 53 (87)
0.554
28 (82) 43(86)Caucasian, n(%)
Asian, n(%) 3 (4) 1 (4) 2 (3) 1 (3) 2 (4)
Black, n(%) 8 (10) 3 (13) 5 (8) 4 (12) 4 (8)
American Indian/Alaskan Native, n(%) 2 (2) 1 (4) 1 (2) 1 (3) 1 (2)
Primary Diagnosis Category
57 (68) 17 (74) 40 (66)
0.770
24 (71) 33 (66)Neurologic n(%)
Respiratory n(%) 3 (4) 1 (4) 2 (3) 1 (3) 2 (4)
Medical n(%) 8 (10) 1 (4) 7 (11) 4 (12) 4 (8)
Cardiac n(%) 4 (5) 1 (4) 3 (5) 1 (3) 3 (6)
Infections n(%) 4 (5) 0 (0) 4 (7) 0 (0) 4 (8)
Substance Abuse n(%) 8 (10) 3 (13) 5 (8) 4 (12) 4 (8)
Physiologic State
52 (62) 9 (39) 43 (70) 0.008 16 (47) 36 (72)Neurology n(%)
Nephrology n(%) 14 (17) 4 (17) 10(16) 0.999 5 (15) 9 (18)
Hepatic n(%) 6 (7) 2 (9) 4 (7) 0.663 3 (9) 3 (6)
Infection n(%) 29 (35) 6 (26) 23 (38) 0.318 8 (24) 21 (42)
Variable Overall SA on Day No SA on Day P value SA on Day No SA on Day
1 to 2 1 to 2 1 to 5 1 to 5
N 84 23 61 34 50
Sepsis n(%) 11 (13) 1 (4) 10 (16) 0.275 2 (6) 9 (18)
Anoxia n(%) 7 (8) 0 (0) 7 (11) 0.182 0 (0) 7 (14)
Alcohol Abuse n(%) 11 (13) 4 (17) 7 (11) 0.483 4 (12) 7 (14)
Drug Abuse n(%) 4 (5) 1 (4) 3 (5) 0.999 2 (6) 2 (4)
Dementia n(%) 5 (6) 0 (0) 5 (8) 0.316 1 (3) 4 (8)
Cancer n(%) 12 (14) 2 (9) 10 (16) 0.497 4 (12) 8 (16)
Encephalopathy n(%) 28 (33) 5 (22) 23 (38) 0.166 7 (21) 21 (42)
Development Disability n(%) 8 (10) 0 (0) 8 (13) 0.100 1 (3) 7 (14)
Seizure n(%) 2 (2) 1 (4) 1(2) 0.475 1 (3) 1 (2)
Lab Values
62(74) 15 (65) 47 (77) 0.271 24 (71) 38 (76)WBC n(%)
Abnormal Creatinine n(%) 39 (46) 5 (22) 34 (56) 0.007 12 (35) 27 (54)
Potassium n(%) 30(36) 7 (30) 23 (38) 0.535 11 (32) 19 (38)
Sodium n(%) 21 (25) 4 (17) 17 (28) 0.323 6 (18) 15 (30)
SA=Sleep Architecture; SD=Standard Deviation; WBC=White Cell Blood Count.
*N for APACHE III was different: Only 76 or 84 had score
Characteristics of patients with sleep architecture Days 1 and 2. Patients were
grouped into exhibiting the presence or absence of sleep architecture over Days 1 to 2 of cEEG 
monitoring. Sleep architecture was present for 23 patients (27%) over Days 1 to 2 of cEEG 
monitoring. Sleep architecture was not detected for 61 patients (73%) during the same time 
period. During Days 1 to 2, there were few differences in characteristics between patients with 
and without sleep architecture. Neurology was the only physiological state that was 
statistically significant (p=0.008). An abnormal serum creatinine was the only lab value 
associated with no sleep (p=0.007). (See Table 4.1).
Characteristics of patients with sleep architecture Days 1 to 5. Patients were also
grouped by the presence or absence of sleep architecture in the group Days 1 to 5 of cEEG 
monitoring, including patients who had sleep data in the time frame of 1 to 5 days. Sleep 
architecture was present for 34 patients. Using this grouping criterion, 34 patients (40%) has sleep 
architecture compared to 50 (60%) with no sleep architecture. There were few differences in 
characteristics between groups. The APACHE III score was significantly higher in the no sleep 
architecture group (p<0.004). Neurology (p=0.021), anoxia (0.038), and encephalopathy 
(p=0.041) were the only physiological states that were observed more often in the group without 
sleep architecture. (Table 4.1).
Medication Dosing
As shown in Table 4.2, propofol was the only medication in which the dosage group was 
statistically significant (p=0.025) for the group Days 1-2. Of the patients who had sleep 
architecture, the majority (61%) had no propofol administered. For patients who had no sleep 
architecture, 24 (39%) received dosage of <2500 mcg and 18 (30%) received ≥2500 mcg. In Days 
1 to 5, there were no significant differences in medication administration between groups with or 
without sleep architecture.
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Table 4.2
Medication Dosing Overall and by Presence or Absence of Sleep Architecture Grouped Days 1 to 2 and Days 1 to 5
Variable Overall SA No SA P Overall SA No SA
n(%) Days 1 to 2 n(%) Days 1 to 2 n(%) value n(%) Days 1 to 5 n(%) Days 1 to 5 n(%)
N=84 N=23 (27) N=61 (73) N=84 N=34 (40) N=50 
Morphine Equivalents 0.95
Dose None 24(29) 7(30) 17(28) 21(25) 7(21) 14(28)
Dose <40mg 25(30) 7(30) 18(30) 29(35) 14(41) 15(30)
Dose ≥40mg 35(42) 9(39) 26(43) 34(40) 13(38) 21(42)
Benzodiazepine 0.84
Equivalents
Dose None 41(49) 11(48) 30(49) 33(39) 12(35) 21(42)
Dose <2mg 22(26) 7(30) 15(25) 30(36) 14(41) 16(32)
Dose ≥2mg 21(25) 5(22) 16(26) 21(25) 8(24) 13(26)
Propofol 0.025
Dose None 33(39) 14(61) 19(31) 32(38) 15(44) 17(34)
Dose <2500mcg 27(32) 3(13) 24(39) 34(40) 12(35) 22(44)
Dose ≥2500mcg 24(29) 6(26) 18(30) 18(21) 7(21) 11(22)
Dexmedetomidine 0.65
None or any (%) 25(30) 6(26) 19(31) 12(35) 18(36)
Predicting Sleep Architecture Days 1 to 2
All baseline characteristics other than APACHE III were considered and included in 
models if they were significant at p < 0.2 in the bi-variate analysis. While no primary diagnosis 
was found to be relevant, having a neurologic physiologic state (p<0.008) was significantly 
associated with no sleep. Since medications such as opioids, benzodiazepines, propofol, and 
dexmedetomidine have known associations with changes in sleep architecture (Weinhouse & 
Watson, 2003; Kondili et al., 2012; Romagnoli et al., 2018), these variables along with age 
were used to adjust predictors to determine their association with sleep architecture. Abnormal 
serum creatinine (p=0.02) was significantly associated and neurologic physiologic state trended 
toward significance (p=0.051) with no sleep architecture. (Table 4.3)
Table 4.3
Single Predictor Logistic Regression Models Predicting Absence of Sleep Architecture
Days 1 to 2 with Continuous Electroencephalogram Monitoring Adjusted by Age & Medications
Variable Odds Ratio 95% P Value
Estimates Confidence
intervals
Neurology Physiologic State 3.17 0.99-10.08 0.051
Encephalopathy Physiologic State 2.06 0.66-7.28 0.265
Abnormal Serum Creatinine 4.62 1.28-16.69 0.020
In multivariate regression, significant variables associated with presence or absence of 
sleep architecture in previous analyses (Table 4.1) were included as candidates in model testing 
and development. The final multivariate regression model (entering age, medications, abnormal 
serum creatinine and neurologic physiologic state) found that abnormal serum creatinine was 
4.35 times more likely to be associated with no sleep architecture (CL 1.15-16.45, p=0.031) 
(Table 4.4).
80
Table 4.4
Multivariate Regression Models Predicting Absence of Sleep Architecture Days 1 to 2 
with Continuous Electroencephalogram Monitoring Adjusted by Age & Medications
Variable Odds Ratio 95% P Value
Estimates Confidence
Intervals
Neurology Physiologic State 2.92 0.86-9.87 0.086
Abnormal Serum Creatinine 4.35 1.15-16.45 0.031
Both developmental disability (p=0.047) and encephalopathy physiologic state (p=0.05) were
associated with no sleep architecture adjusting for age and medications (Table 4.5).
Single Predictor Logistic Regression Models Predicting Absence of Sleep Architecture for Days 
1 to 5 with Continuous Electroencephalogram Monitoring Adjusted by Age & Medications
Variable Odds Ratio 95% P Value
Estimates Confidence
Intervals
Neurology Physiologic State 2.60 0.93-7.54 0.071
Infection Physiologic State 2.37 0.85-7.12 0.109
Sepsis Physiologic State 3.62 0.79-26.34 0.132
Encephalopathy Physiologic State 3.14 1.04-10.53 0.050
Development Disability 10.63 1.40-227.33 0.047
Physiologic State
Abnormal Serum Creatinine 2.28 0.82-6.69 0.121
Multivariate regression model including developmental disability and encephalopathy 
physiologic states, adjusted for age and medications, found that development disability was 
18.52 times more likely to be associated with no sleep architecture (CL 1.63-210.04, p=0.019). 
Encephalopathy was 4.53 times more likely to be associated with no sleep architecture (CL 1.33-
15.43, p=0.016) (Table 4.6).
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Table 4.6
Multivariate Regression Model Predicting Outcome Absence of Sleep Architecture with Days 
1 to 5 of Continuous Electroencephalogram Monitoring Adjusted by Age & Medications
Variable Odds Ratio 95% P Value
Estimates Confidence
Intervals
Development Disability 18.52 1.63-210.04 0.019
Physiologic State
0.016Encephalopathy Physiologic State 4.53 1.33-15.43
The outcome variables hospital length of stay, ICU length of stay and mechanical 
ventilation days were all significant in Days 1 to 2 of sleep architecture data. The hospital length 
of stay overall ranged 2-68 days with a median of 11 days. The median hospital length of stay 
for subjects with sleep architecture was 7 days ranging from 2 to 27 days. In contrast, the median 
hospital length of stay for patients with no sleep architecture was 14 days ranging 2 to 68 days 
(Table 4.7). The overall ICU length of stay ranged 2 to 44 days with a median of 4. For subjects 
with sleep architecture, the median ICU length of stay was 3 days ranging from 2-16 days. The 
median ICU length of stay for subjects with no sleep architecture was 8 days ranging from 2-44 
days. Mechanical ventilation days for subjects exhibiting sleep architecture Days 1 to 2 ranged 
from 1-11 days with a median of 2 days. For subjects with no sleep architecture, the median 
mechanical ventilation days was 6, ranging from 2-32 days (Table 4.7).
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Table 4.7
ICU and Hospital Days, Mechanical Ventilation Days and Presence or Absence of 
Sleep Architecture Overall and by Groups: Days 1 to 2 and Days 1 to 5
Variable Overall SA No SA P SA No SA P
Median Days 1 Days 1 to Value Days 1 to Days 1 to Value
(range) to 2 2 5 5
N=84 Median Median Median Median
(range) (range) (range (range)
N=23 N=61 N=34 N=50
ICU days 6.5 (2-44) 3 (2-16) 8 (2-44) <.001 4 (2-44) 8 (2-32) 0.001
Hospital 11 (2-68) 7 (2-27) 14 (2-68) <.001 8.5 (2-68) 15 (2-64) 0.002
days
N=72 N=16 N=56 N=27 N=45
Mechanical 5 (1-32) 2 (1-11) 6 (2-32) 0.003 3 (1-29) 6 (2-32) 0.006
ventilation
days
SA=Sleep Architecture; ICU=Intensive Care Unit; LOS=Length of Stay. Mann-Whitney U tests
When considering presence or absence of sleep architecture Days 1 to 5 with cEEG
monitoring, hospital length of stay, ICU days and Mechanical ventilation days were all
significant. For patients in the group having sleep architecture, the median length of stay was 8.5
days ranging 2-68 days. The patients in the group with no sleep architecture had a median 15 days
hospital length of stay (range: 2-64 days).
The presence or absence of sleep architecture was associated with outcomes of post
hospital discharge placements or death. In looking at sleep up to two days monitoring, the
association between sleep architecture and hospital outcome/discharge placement was significant
(p=0.006). (Table 4.8).
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Table 4.8
Hospital Outcome or Placement of Patients in Groups with and without Sleep Architecture 
(Days 1 to 2 and Days 1 to 5)
Variables Overall SA Days No SA P SA Days No SA P
n(%) 1 to 2 Days 1 to 2 value 1 to 5 Days 1 to 5 value
N=84 n(%) n(%) n(%) n(%)
N=23(27) N=61(73) N=34(40) N=50(60)
ICU Outcome
8 (10) 1 (4) 7 (11)
0.420
1(3) 7(14)
0.330
Death
Home 6 (7) 17 (13) 3 (5) 3(9) 3(6)
LTACH 9 (11) 1 (4) 8 (13) 4(12) 5(10)
Rehab 1 (1) 0 (0) 1 (2) 1(3) 0(0)
Hospital 60 (71) 18 (78) 42 (69) 25(74) 35(70)
Unit
Hospital
10 (12) 1 (4) 9 (15)
0.006
1(3) 9(18)
0.003
Outcome
Death 31 (37) 17 (74) 14 (23) 21(62) 10(20)
Home 12 (14) 1 (4) 11 (18) 3(9) 9(18)
Nursing 11 (13) 2 (9) 9 (15) 5(15) 6(12)
Home 12 (14) 2 (9) 10 (16) 4(12) 8(16)
LTACH 4 (5) 0 (0) 4 (7) 0(0) 4(8)
Rehab 1 (1) 0 (0) 1 (2) 0(0) 1(2)
Inpatient 3 (4) 0 (0) 3 (5) 0(0) 3(6)
Psych
Group
Home
Hospice
SA=Sleep Architecture; LTACH=Long term acute care hospital; Psych=Psychiatric unit
Across groups overall, ten subjects died. However, death was not associated with the
presence or absence of sleep architecture. Thirty-one subjects were discharged home from the
hospital. Because the Hospital Outcome/Placement variable was significant, analysis was done to
determine whether there were differences in presence or absence of sleep architecture and
discharge home. Significantly, seventeen subjects with sleep architecture in the Days 1 to 2 group
were discharged to home (p<0.001; test not in table). ICU outcome or discharge location was not
found to be associated with sleep architecture. Adjusting for age and medications, the presence of 
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sleep architecture was 8.76 times more likely to result in a discharge to home (CL 2.35-38.89,
p=0.002) (Table 4.9).
Table 4.9
Multivariate Regression Model Predicting Discharge Home Adjusted by Age & Medications
VariableOdds ratio 95% P value
Confidence
Intervals
Creatinine 0.43 0.10-1.66 0.229
Sleep Architecture 8.76 2.35-38.89 0.002
Day 1 to 2
In patient group Day 1 to 5, ICU discharge outcome was also not significant. In this 
group, hospital discharge location was found to be associated with the presence or absence of 
sleep. Nine out of ten subjects who died out of this group did not have sleep architecture. 
Disposition to home from the hospital adjusting for age, medications, developmental disability 
and encephalopathy physiologic states was 15.92 (CL 3.94-86.13, p<0.001) times more likely to 
be associated with the presence of sleep architecture during days 1-5 of cEEG monitoring (Table 
4.10). It is noted that persons with developmental disability may not have resided at home pre-
hospitalization, thus contributing to the non-significance of p value (p=0.78).
Table 4.10
Multivariate Regression Model Predicting Discharge Home Adjusted by Age & Medications
Variable Odds ratio 95% Confidence P value
Intervals
Developmental 1.42 0.11-17.03 0.78
Disability
0.003Encephalopathy 13.85 2.46-109.55
Sleep Architecture 15.92 3.94-86.13 <0.001
Days 1 to 5
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Discussion
This study uniquely examined the presence or absences of sleep architecture and 
associated short term outcomes. A study showed that at three months post discharge, poor 
functional outcomes in subarachnoid hemorrhage patients was associated with no sleep 
architecture over 24 hours per cEEG controlling for age, grade SAH and extent of hemorrhage on 
CT scan (Claassen et al., 2006). In status epilepticus patients, the only cEEG feature significantly 
associated with complete functional recovery at discharge was stage 2 sleep architecture (Alvarez 
et al., 2015). In contrast, this study found more immediate impact on patient outcomes were 
associated with no sleep architecture during days 1-2 of cEEG monitoring. No sleep architecture 
in the ICU in patients grouped Days 1 to 2 of cEEG was associated with patient outcomes such 
as longer mechanical ventilation days, ICU length of stay, and hospital length of stay.
Age. While this study found that age was not significantly associated with the presence 
or absence of sleep architecture, aging has a known impact on sleep. Growing older results in 
decreased total sleep time, sleep efficiency and sleep latency. Even in healthy individuals, sleep 
architecture changes with age showing increased percentage of time in sleep stages 1 and 2 and 
decreased time in slow wave and REM sleep (Espiritu, 2007; Moraes et al., 2014). Adding a 
critical illness and the ICU environment, theoretically results in even further sleep disturbances 
such as no normal sleep architecture.
Disease Severity. Knowledge related to severity of disease and sleep is limited. 
Severity of disease scores have been associated with mortality in various disease states such as 
sepsis, kidney disease and pancreatitis (Kamdar, Needhan & Collop, 2012; Talib et al., 2017;
Sundararajan et al., 2017). However, in these studies, patients’ sleep states were not measured. 
The findings of this study showed an association with severity of disease measured by APACHE 
III scores with the absence of sleep in during both the cEEG monitoring over 1-2 or 1-5 days.
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Critical illness is thought to be a factor in the difference in sleep architecture to the point that a 
new classification of sleep analysis for these patients is being explored (Drouot et al., 2011; 
Watson et al., 2013). It may be that critical illness in itself does not impact sleep but the 
severity of the critical illness contributes to the presence or absence of sleep architecture.
Sedation and Sleep. Sedation and sleep share similar characteristics such as a decreased
response to external stimuli, decreased muscle tone and respiratory depression. Sedation 
medication affect the same neuro pathways used in the transition from wakefulness to sleep. 
However, sleep is subjected to circadian rhythms and progresses through stages, while sedation 
does not. The impact of sedation is drug and dose dependent (Weinhouse & Watson, 2009). 
Sedation may have both positive and negative impact on sleep. Benzodiazepines have been found 
to increase sleep duration and the light sleep stages 1 and 2 (Engelmann et al., 2014). Stage 2 
sleep has increased sleep spindles and there is a considerable suppression of slow wave sleep 
(Weinhouse & Watson, 2009). Opioids are analgesics but can have a sedative effect. Opioids 
increase stage 2 and REM sleep while decreasing SWS (Weinhouse & Watson, 2009). Pain can 
cause sleep disturbances and sleep disturbances can increase the perception of pain (Fu et al., 
2018). Therefore, opioids can also have a positive impact on sleep. Propofol suppresses SWS and 
seems to have no appreciable effect on REM sleep. Propofol seems to enhance sleep and patients 
have stated they felt rested after low dose propofol. High dose propofol and benzodiazepines can 
result in burst suppression per EEG leading to no sleep architecture being observed (Kondili et 
al, 2012; Weinhouse & Watson, 2009). Dexmedetomidine can increase stage 2 and decrease the 
percentage of REM sleep (Rigmagnoli et al., 2018). In this study during 1-2 days cEEG 
monitoring (Days 1 to 2), only propofol was found to have a significant association with the 
presence or absence of sleep architecture. Sedating medications may have a positive impact on 
sleep by increasing sleep time. However, negative consequences on sleep may also occur leading
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to less time in the restorative sleep stages. These negative consequences appear to be dose 
dependent. This study attempted to address different dosages of all medication except 
Dexmedetomidine, but what constitutes a lower dose that is less likely to negatively impact 
sleep architecture has not been explored. The study data also does not provide the opportunity 
for investigators to distinguish between continuous and intermittent administration. The 
consequences related to sedation medications’ method of administration on sleep is unknown.
Abnormal Creatinine. Abnormal serum creatinine levels were found to be 
significantly related to no sleep architecture Days 1 to 2 group but not in Days 1 to 5 group. 
Even though serum creatinine levels were significant, nephrology physiologic state was not. 
Creatinine levels are related to muscle metabolism. An abnormal creatinine level may be lower 
or higher than the standard norms. Low creatinine levels may be related to spinal cord injuries, 
cachexia, neuromuscular blocking agents or a sudden decrease in activity as can occur with a 
critical illness. High creatinine levels can occur with preeclampsia, dehydration, renal issues, 
rhabdomyolysis, blocked urinary tract, myasthenia gravis, hyperthyroidism and muscular 
dystrophy (Renal Function Tests, n.d.). No evidence is available that any of these conditions in 
themselves have a direct impact on sleep architecture.
Physiologic state neurology. While a primary neurologic diagnosis was not significantly
associated with the presence or absence of sleep architecture, a neurologic physiologic state was 
per bivariate analysis. Continuous EEG monitoring is usually implemented in the presence of 
seizures or to rule out non-clinical seizure activity evidenced by an unexplained change in level 
of consciousness. Non-clinical seizure activity is associated with neurosurgical procedures, 
metabolic derangements, acute neurologic injury, drug related neurotoxicity and transplant 
patients (Friedman, Claassen, Hirsch, 2009). Thus, sleep disturbances resulting in no sleep 
architecture related to neurology diagnoses or comorbidities would expect to be present. In fact,
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many studies utilizing polysomnography in critically ill patients excluded patients with 
neurologic diagnoses. However, after adjusting for age, medications and abnormal creatinine 
where appropriate, a neurology physiologic state was no longer associated with no sleep 
architecture. Other studies have found that severe neurologic diagnoses do not preclude sleep 
architecture. Sandsmark and colleagues (2016) showed that 19 of 64 severe traumatic brain 
injury patients had sleep architecture in the acute phase per cEEG. Neurologic patients are still 
capable of exhibiting sleep architecture even in the presence of severe disease and exploring the 
impact of the presence or absence of sleep architecture in these patients is a research opportunity.
Physiological state encephalopathy. Encephalopathy is a medical term for any
condition resulting in altered brain function or structure leading to a maladjusted mental state
(National Institute of Neurological Disorders and Stroke, 2018). Encephalopathy may be caused
by infection, metabolic or mitochondrial dysfunction, brain tumor, increase intracranial pressure,
toxins, progressive trauma, poor nutrition, hypoxia, or poor cerebral blood flow (National
Institute of Neurological Disorders and Stroke, 2018). This study found encephalopathy was
associated with no sleep architecture after accounting for age, medications and developmental
disability during the cEEG period of patients in group Days 1 to 5. Other research found patients
with hepatic encephalopathy to have disturbed sleep architecture with decreased REM but in
these non-critically ill patients sleep architecture was still present. Further information related to
encephalopathy and the state of sleep architecture is needed. Encephalopathy is a broad term and
it is currently unknown whether certain triggers of the disease are more likely to impact sleep.
Physiologic state developmental disability. Eight subjects had a developmental
disability. In the Days 1 to 2 group, no developmentally disabled patients had sleep architecture, 
so a statistical model could not be developed. Looking at the presence or absence of sleep 
architecture in the group having monitoring Days 1-5, developmental disability was found to have
89
a likelihood of no sleep architecture. However, the model had an extremely large confidence 
interval [CI 1.4-227.3] indicating that more research is needed in this area. In fact, no studies 
were found exploring sleep in patients with developmental disabilities in the hospital setting let 
alone in the ICU environment. However, experts indicate that the ICU environment is 
particularly difficult, unfamiliar and stressful for these subjects (Hsieh et al., 2012; Iacomo et al., 
2014). Standards of care for the developmentally disabled indicate that routines, lighting, noise 
levels and the number of people coming into the room should be controlled to ease the stress for 
these patients-a sometimes difficult prospect in the ICU (Ailey, Ulmali, & Uyen, 2012). More 
research is needed to determine if the critical illness, the ICU setting, or both are mainly 
responsible for the likelihood of no sleep in this patient population.
Length of Stay Outcome. The presence of sleep architecture and patient outcomes has
been studied mainly in the neurological primary diagnosis population. Patients suffering from 
severe traumatic brain injury with sleep architecture per cEEG had significantly shorter ICU stays 
and showed a trend towards significantly shorter hospital stays (Sandsmark et al., 2016). In the 
current study, when an absence of sleep architecture was noted in the group Days 1 to 2 of cEEG 
monitoring, there was significant association with an increase in ICU and hospital length of stay. 
Furthermore, increased mechanical ventilation days were also significantly associated with the 
absence of sleep architecture. Longer mechanical ventilation days intuitively would be related to 
longer ICU stays. The absence of sleep architecture in patients with monitoring Days 1 to 5 was 
associated with a longer hospital length of stay but not a longer ICU stay or mechanical 
ventilation days. Lack of sleep architecture Days 1 to 2 was associated with increased length of 
stays. However due to the number of patients who obtained sleep architecture during days 3-5 
(who were added in the Days 1 to 5 group), an association between mechanical ventilation days 
and ICU length of stay no longer significant. Implementing interventions to improve sleep as
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soon as possible in critically ill patients may potentially decrease mechanical ventilation 
days, ICU length of stays and hospital days.
Posthospitalization transfer location. An association between the presence of sleep
architecture and posthospital transfer location has been found in various studies. Purandare and 
colleagues (2018) discovered that the presence of stage 2 sleep in critically ill intracranial 
hemorrhage patients was not associated with death. In severe traumatic brain injury patients, the 
presence of sleep architecture was associated with the disposition from the hospital to home or 
acute rehabilitation. The current study found a significant association between the presence or 
absence of sleep architecture Days 1 to 2 and Days 1 to 5 in persons with cEEG monitoring and 
hospital disposition such as death, home, nursing home, long term acute care hospital, inpatient 
psychiatric unit, group home, or hospice. For both monitoring periods, the presence of sleep 
architecture was associated with the patient being discharged home from the hospital. Assessing 
for the presence of sleep architecture may give clinicians, families and patients helpful 
prognostic information.
Conclusion
This study found a number of factors that were associated with the presence or absence of 
sleep architecture as measured by cEEG monitoring in critically patients. No matter the length of 
cEEG monitoring, the greater the severity of disease and a neurologic physiologic state was found 
to be associated with no sleep architecture. In this study, no particular type of primary diagnosis 
documented in the medical record significantly impacted sleep architecture. However, certain 
secondary diagnoses or comorbidities did have an association with the state of sleep architecture. 
However, while an anoxic, encephalopathy and developmental disability physiologic states were 
associated with no sleep architecture, the actual number of subjects with these conditions was 
small. In the group having monitoring Days 1 to 2 but not the group having monitoring Days 1 to
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5, propofol and creatinine were significant, while there was a trend of an association with 
increased age and no sleep architecture. Some of the differences could be related to the reasons 
cEEG monitoring is ordered leading to a decrease use of sedation medications like propofol. 
Often, sedation is started at admission to the ICU related to various procedures including 
intubation, but will be weaned to minimal levels to assess level of consciousness and 
neurologic status. Additional research is needed to explore further associations between patient 
characteristics and sleep.
Using cEEG monitoring is commonplace in the ICU making it easier to implement 
compared to polysomnography. Assessing for sleep using cEEG in patients beyond those who 
have it ordered as part of their plan of care could expand ICU sleep knowledge.
While some research has been conducted to determine the presence of sleep architecture 
in critically ill patients with neurological disorders and the patients’ outcomes, the number of 
studies is sparse. The finding that no sleep architecture is associated with length of stay in the 
ICU and hospital, mechanical ventilation days and hospital disposition needs further exploration. 
This association between sleep and patient outcomes elevates the importance of developing 
evidenced based sleep interventions and their implementation as early as possible in a patient’s 
admission to the ICU.
Limitations. This study had a number of limitations. This is a retrospective study
dependent on chart review data. The cEEG monitoring was ordered as part of the plan of care 
which may have resulted in the patient population being at the more severe end of the clinical 
spectrum. The cEEG monitoring was initiated at different points within the ICU stay, but 
information on when cEEG was initiated per subject was not available. There are other 
medications than the ones reviewed within this study that may impact sleep architecture such as 
beta blockers. Sleep is complex and the multiple predictors that may influence sleep were not
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explored in this study. For example, the ICU environment with its level of noise and light along 
with frequent interruptions related to increased monitoring and interventions may impact the 
ability to sleep. The small sample size limited the number of variables that were able to be 
studied. Severity of disease was found to be significantly associated with the absence of sleep, 
but a limited number of subjects were able to have the APACHE III score calculated from the 
retrospective chart review data. While the knowledge related to patient outcomes of mechanical 
ventilation days, ICU length of stay, hospital length of stay and disposition is worthwhile, 
outcomes post discharge would be valuable. It is noted that there were only a few patients with
developmental disability, these patients may not have resided at home pre-hospitalization, 
therefore it may not be and change to not go home after hospital discharge. However, this is 
unknown. Follow-up of this group in future studies may be warranted.
This study highlights that sleep may be an important part of critically ill patients’ 
recovery and that more research is needed to guide practice and develop evidence-based 
sleep interventions.
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Chapter 5:
Synthesis
This chapter presents the major findings from each manuscript in this dissertation.
First, a synthesis of the state of knowledge based on the findings from this dissertation’s Chapters 
2 and 3 will be given. Second, an overview of the findings from Chapter 4 is provided along with 
the study’s limitations. Finally, implications for future research are discussed.
Chapter 2
Delirium. Delirium is an acute confusional state associated with impaired 
consciousness (Fleminger, 2002). Delirium is exemplified by the new onset of cerebral 
dysfunction, change in baseline cognition, inattention, disorganized thinking and/or an altered 
level of consciousness (Barr & Pandharipanda, 2013; Sendelbach & Guthrie, 2009). Critically ill 
patients have a high risk for delirium with incidences ranging from 11%-80% (McNicoll, 2003; 
Van Rompaey et al., 2009).
Delirium Outcomes. ICU delirium is associated with negative short-term and long-term
outcomes. Patients with delirium are more apt to face acute respiratory distress syndrome 
(ARDS), nosocomial pneumonia, cardiopulmonary edema, self-extubation, re-intubation, cardiac 
arrhythmias, and to be discharged to a skilled nursing facility (Inouye, 2006; Ouimet et al., 2007; 
Yoo, Nakagawa, & Kim, 2013). Mechanical ventilation days and length of stay in the ICU and 
hospital may increase in patients diagnosed with delirium (Ely et al., 2004; Lin et al., 2004).
Critically Ill Patient Sleep. More than half of critically ill patients are found to have
sleep disturbances as demonstrated by abnormal sleep duration, patterns, and architecture 
related to critical illness or the ICU environment. Sleep fragmentation, short bursts of sleep 
resulting in predominant N1 sleep stage with minimal time in the restorative sleep stages SWS 
or REM, is a common ICU finding (Bijwadia, 2009).
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Delirium and Sleep. Slow wave sleep contributes to physiologic repair. Slow wave sleep
allows the brain to appropriately process new sensory input during the next wake period. This 
permits a person to acquire new information. Different aspects of REM and NREM sleep are 
necessary for learning and memory. Theoretically, sleep disturbances that negatively impact SWS 
and REM sleep could lead to delirium as memory, learning and the ability to process new 
situations are impacted. Ongoing sleep interruption and deprivation leads to cognitive impairment 
(Sanders & Mace, 2010). Delirium etiology is not known; however, the prefrontal cortex and 
posterior parietal cortex are both impacted by sleep deprivation and delirium (Maldonado, 2013; 
Weinhouse et al., 2009). Neurotransmitter imbalance may be related to both delirium and sleep 
disturbances. The exact mechanism by which the impaired neurocognition of delirium occurs is 
unknown whether by sleep deprivation, neurotransmitter derangement or a combination of both.
Findings. A literature review found seven articles that measured both sleep and delirium
in critically ill patients. The findings were mixed in determining if there was an association 
between sleep disturbances and delirium. Not all instances of a reduction in total sleep time or 
REM sleep was associated with delirium. Four of the studies used patient questionnaires to 
measure the quality and quantity of sleep, so an exploration of sleep architecture and delirium 
was not able to be conducted in more than half the studies. Theoretically sleep and delirium may 
have a causal relationship. This possible relationship may be related to the absence of slow wave 
and REM sleep which cannot be measured by questionnaires. Further research is needed to 
explore the theoretical associations between sleep architecture and delirium particularly using 
sleep measurement methods that capture the presence or absence of sleep architecture. The 
presence or absence of sleep architecture may result in delirium, which has been linked to 
negative patient outcomes. More research is needed to explore the variables related to critically 
ill patients’ sleep architecture disturbances, delirium and patient outcomes.
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Chapter 3
Sleep Measurement in the ICU Environment. Critical illness and the ICU 
environment can interfere in the measure of sleep in critically ill patients. Critical illness 
effecting level of consciousness and/or memory could impact the accuracy of patient self-report 
sleep questionnaires (Bourne et al., 2007). Nurses mainly use physical cues to determine 
patients’ sleep status for provider sleep assessment tools. However, critical illness and sedating 
medications may result in closed eyes and decreased movement resulting in an over report of 
sleep (Ritmala-Castran et al., 2016; Bourne et al., 2007; Richards, O’Sullivan, & Phillips, 2000). 
Actigraphy utilizes an algorithm that takes patient movement data to determine sleep/wake 
cycles. Critical illness can result in muscle weakness and decreased physical movement 
potentially confounding actigraphy sleep findings actigraphy (Bourne, 2007; Van der Kooi et al., 
2012; Schwab et al. et al., 2018). Bispectral index (BIS) monitors brain waves but does not 
differentiate sleep into its various stages. BIS can give total sleep time information, but 
neurological trauma, dementia, and delirium can impact BIS values which may falsely be 
interpreted as adding to total sleep time (Bourne, 2007). Sleep self- reports, nurse sleep 
assessments, BIS and actigraphy have challenges to reliably measure sleep in critically ill 
patients.
Polysomnography and Critically Ill Patients. Polysomnography (PSG) is considered
the gold standard of sleep measurement. PSG is comprised of EEG electrodes along with 
electrodes to measure eye and muscle movement. The use of PSG in the ICU environment has 
challenges related to expense, technical interference and ability to obtain data on recruited 
subjects. Since 2000, twenty-six articles were found to have used PSG to measure sleep in the 
ICU environment. Thirteen had less than 24 hours of PSG data per subject even though research 
has shown that a significant amount of ICU sleep occurs during daytime hours. The expense of
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implementing PSG may be the reason for shorter data collection periods. Eighteen of the studies 
had subjects with missing PSG data. The reasons for missing data include: subject withdrawal, 
artifact, abnormal PSG, inaccurate PSG, missed ventilator data, respiratory distress, hypoxia, 
sepsis, poor signal quality or technology limits. However, the standards used to determine what 
data is used or discarded is not clearly articulated. Traditional PSG with multiple potentially 
uncomfortable scalp electrodes is monitored by technicians for electrode conductivity which adds 
to PSG expense. Technicians adjusting electrodes during a study can interrupt sleep and lead to 
subject dissatisfaction. Due to the expense of PSG, difficulty in initiating and obtaining sleep 
data, many studies use extensive inclusion and exclusion criteria to try to obtain reliable sleep 
data from every subject. Finally, some critically ill patients have abnormal PSG findings without 
the presence of normal sleep architecture leading to a theory that these patients have a different 
sleep architecture (Watson et al., 2013).
Continuous Electroencephalogram (cEEG). Continuous electroencephalogram is a
diagnostic procedure that is common in ICUs that measures brain waves including some sleep 
stages. Since cEEG does not measure eye or muscle movement, it is not able to differentiate 
between stage 1 and rapid eye movement sleep. However, cEEG can capture stage 2 and slow 
wave sleep. While some of the same technical issues exists between PSG and cEEG that may 
result is missing data, cEEG is easier to implement with less expense meaning that larger 
sample sizes could be enrolled.
Findings. Measuring sleep in critically ill patients has challenges. Researchers need to 
be sure of what knowledge they wish to explore about sleep to determine the best sleep 
measurement. PSG gives the most detailed sleep information, but at a higher cost and potential 
for missed data for a variety of reasons. Additionally, extensive inclusion and exclusion criteria 
limits the critically ill patient population from which sleep knowledge is gathered. Sleep
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measured by cEEG can give information about the presence or absence of sleep architecture 
and including the restorative SWS. Exploring the presence and amount of state 2 and SWS 
from larger sample sizes would add to the state of sleep knowledge in the critically ill patient. 
This knowledge can be used to determine sleep barriers, sleep interventions and patient 
outcomes related to sleep.
Chapter 4
Predictors of Sleep Architecture. The retrospective chart review of 84 patients looked
at predictors associated with the presence or absence of sleep architecture Days 1 to 2 and Days 
1 to 5 of cEEG monitoring. Severity of disease was by bivariate analysis significantly associated 
with the absence of sleep architecture for both groups. Abnormal creatinine and propofol were 
both associated with the absence of sleep architecture during days 1-2 of cEEG monitoring. No 
primary diagnosis was associated with the presence or absence of sleep architecture. However, a 
neurologic physiological state was associated with no sleep Days 1 to 2 and Days 1 to 5 of 
having cEEG. The neurologic physiological state when adjusted for age, medications and 
abnormal serum creatinine no longer remained significant. Days 1 to 5 cEEG, no sleep 
architecture was significantly associated with the physiologic states of anoxia, encephalopathy, 
and developmental disability. No subjects with anoxia had sleep architecture so anoxia was 
excluded as a predictor variable in models. A multivariate regression model with 
encephalopathy, developmental disability, age and medications as predictors resulted in both 
physiological states remaining significantly associated with no sleep architecture.
Sleep Architecture and Patient Outcomes. The presence or absence of sleep
architecture was associated with various patient outcomes. No sleep architecture during days 1-2 
cEEG was associated with longer mechanical ventilation days, ICU length of stay and hospital 
length of stay. In contrast to days 1-2 cEEG to days 1-5 cEEG, eleven more subjects had sleep
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architecture. No sleep architecture during days 1-5 was significantly associated with a longer 
hospital length of stay, but mechanical ventilation days and ICU length of stay is no longer 
significant.
Hospital disposition was found to be significantly associated with no sleep architecture for 
both groups, Days 1 to 2 cEEG and Days 1 to 5 cEEG. Discharge to home was the most common 
posthospitalization discharge location. After adjusting for age, medications and abnormal serum 
creatinine, the presence of sleep architecture during Days 1 to 2 group having cEEG was associated 
with a discharge home from the hospital. In the Days 1 to 5 group having cEEG, the presence of 
sleep architecture adjusting for age, medications, encephalopathy and developmental disability 
physiological state was significantly associated with discharge to home.
Limitations. This study had a number of limitations. This is a retrospective study
dependent on chart review data. The cEEG monitoring was ordered as part of the plan of care which 
may have resulted in the patient population being at the more severe end of the clinical spectrum. 
Continuous EEG is usually ordered in the presence of unexplained decreased level of consciousness 
with a concern for subclinical seizures. Additionally, the cEEG monitoring was initiated at different 
points within the ICU stay. There are other medications than the ones reviewed within this study that 
may impact sleep architecture such as beta blockers. Sleep is complex and the multiple predictors 
that may influence were not all explored in this study. For example, the ICU environment with its 
level of noise and light along with frequent interruptions may impact the ability of patients to sleep. 
These variables were not included in this study. However, the small sample size limited the number 
of variables that were able to be studied. Severity of disease was found to be significantly associated 
with the absence of sleep but a limited number of subjects were able to have the APACHE III score 
calculated from the retrospective chart review. Therefore, in view of the small sample size, 
APACHEIII scores were
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not included in statistical models. While the outcomes of mechanical ventilation days, ICU 
length of stay, hospital length of stay and disposition have value, outcomes post discharge would 
be valuable.
Synthesis. The exploratory retrospective study found associations between sleep
architecture and patient outcomes. Longer mechanical ventilation days, ICU and hospital length 
of stays were all associated with the absence of sleep architecture as measured by no stage 2 or 
slow wave sleep per cEEG. The absence of sleep architecture was associated with propofol, 
abnormal serum creatinine and physiological state of a neurologic nature, encephalopathy, and 
developmental disability. Delirium has also been found to be related to negative patient 
outcomes (Ely et al., 2004; Van Rompaey et al., 2009). Delirium is theoretically associated with 
sleep disturbances, but minimal research has been conducted to support this theory. No or 
minimal restorative slow wave or rapid eye movement sleep may result in delirium possibly due 
to impaired memory consolidation or the brain’s inability to process new information. Even so, 
delirium prevention and interventions include promoting sleep (Barr et al., 2013). This 
exploratory retrospective study did not include delirium as a possible predictor.
The research study of this dissertation explored the presence or absence of sleep 
architecture. Measuring sleep in the critically ill can be challenging. As an exploratory study, an 
overview of the presence or absence sleep architecture was chosen, but the presence of certain 
sleep architecture stages can be determined by cEEG. Polysomnography can capture all sleep 
stages and may be the appropriate choice to answer certain research questions. However, PSG is 
expensive and is rarely implemented in the ICU environment. The less expensive and the 
frequently implemented in the ICU cEEG is able to recognize stage 2 and slow wave sleep 
which could be an appropriate sleep architecture measurement tool that allows for larger sample 
sizes than normally seen with PSG.
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This dissertation has identified areas where there is a deficit of scientific knowledge and 
would benefit from further research. The possible relationship between sleep architecture and 
delirium is a gap in knowledge. Sleep disturbances and deprivation are known to exist in the 
critically ill. However, the factors that interfere with sleep architecture is not fully known. Acute 
hospital outcomes related to sleep disturbances and deprivations that occur in the critically ill 
needs to be explored further. Post discharge long term outcomes related to critically ill sleep 
disturbances should also be explored. Methods of critically ill sleep measurement need to be 
developed or refined. Actigraphy may be refined to capture the presence or absence of sleep in 
the critically ill and as this tool evolves research will be needed to validate its accuracy and 
reliability. Using cEEG possibly with less electrodes may give enough detailed sleep information 
with less expense and missing data that larger sample sizes would be available increasing the 
power of critically ill sleep research.
This dissertation highlights that the sleep state in the critically ill can be significantly 
associated with patient outcomes. Sleep architecture knowledge may have prognostic value 
for clinicians. Evidenced-based sleep promotion interventions based on known predictor 
variables should be implemented as soon as appropriate in the critically ill patient population.
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On 11/9/2018, the IRB reviewed the following submission:
Type of Review: Initial Study
Title of Study: The relationship between patient outcomes and sleep
architecture in critically ill patients
Investigator: Ruth Lindquist
IRB ID: STUDY00004889
Sponsored Funding: None
Grant ID: None
Internal UMN Funding: None
Fund Management None
Outside University:
IND, IDE, or HDE: None
Documents Reviewed • UMD IRB ICU Sleep.docx, Category: IRB Protocol;
with this Submission: • Allina IRB Letter, Category: Other;
The IRB determined that the proposed activity is not research involving human subjects 
as defined by DHHS and FDA regulations. To arrive at this determination, the IRB 
used “WORKSHEET: Human Research (HRP-310).” If you have any questions about 
this determination, please review that Worksheet in the HRPP Toolkit Library and 
contact the IRB office if needed.
Ongoing IRB review and approval for this activity is not required; however, this 
determination applies only to the activities described in the IRB submission and does not 
apply should any changes be made. If changes are made and there are questions about
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whether IRB review is required, please submit a Modification to the IRB for 
a determination.
Sincerely,
Jessica Wright, MA CIP
IRB Analyst
We value feedback from the research community and would like to hear about your 
experience. The link below will take you to a brief survey that will take a minute or 
two to complete. The questions are basic, but your responses will help us better 
understand what we are doing well and areas that may require improvement. Thank 
you in advance for completing the survey.
Even if you have provided feedback in the past, we want and welcome your evaluation.
https://umn.qualtrics.com/SE/?SID=SV_5BiYrqPNMJRQSBn
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